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Abstract 
 
Mesenchymal stromal cells (MSC) are an important cell source for tissue 
engineering and regenerative medicine (TERM) and cell therapies. Intravenous 
injections (I.V.) injections and scaffold implantation are currently the predominant 
methods of MSC administration. However, both approaches have encountered 
serious problems for example with I.V. injections, cells can move through the blood 
stream to any site in vivo provoking problems such as MSC entrapment, and failure 
to target the injury site. For tissue engineering (TE) applications administration of 
MSC to a target area include the fabrication of artificial three dimensional (3D) 
constructs. However, the synthesised environments of these 3D constructs have been 
associated with numerous limitations including, poor cellular responses, lack of cell 
infiltration and limited access to essential nutrients and oxygen through the scaffolds. 
Therefore, the overall aim of the study is to address obstacles associated with MSC 
administration from either I.V. injections or scaffold transplantation, by using a 
jetting methodology called bio-electrospraying (BES) to deliver cells directly to an 
injured region.  
 
A major difficulty associated with BES is reproducibility of data between different 
labs. This is due to the type of apparatus used as electrospray devices tend to be built 
“in-house”, which adversely affects reproducibility of parameters, including 
flowrate, potential difference (PD) and voltages. To overcome these problems we 
used Spraybase
®
, a commercially available electrospray apparatus. We aimed to 
establish optimised “gold standard” parameters, for a commercial electrospray 
instrument that would allow reproducibility between experiments/labs and/or 
medical environments.  
 
By modifying the shape of the ground electrode component, the commercial 
electrospray was transformed into a fully functional electrospinning device.  3D 
constructs were fabricated using our own blends of polymer mixtures involving 
PEO, collagen and agarose. Two distinct sets of electrospun fibres were examined in 
relation to surface texture, pore and fibre size.  
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These preliminary results may benefit future applications for TE either/or by using 
our polymer hybrids, electrospinning apparatus and functional parameters. 
 
Finally, the BES technique was developed further to make it more clinically 
applicable. To achieve this, the jetting process was first explored to investigate its 
affects on mouse bone-derived mesenchymal stromal cells (mBMSC) at a cellular 
and immunological level. Known characterisations of MSC, i.e. expression of 
specific surface markers, suppression of T- cell activation, multilineage 
differentiation, and the pro-reparative properties were analysed for BES BMSC. It 
was determined that BES BMSC behaved similar to their non-BES counterparts in 
all biological aspects. The commercial electrospray was then modified to include a 
specially designed catheter with single needle configuration attached. This catheter 
fits all types of endoscopes suitable for keyhole surgeries. The only adjustment to the 
previous established BES parameters was to the flowrate. This was to accommodate 
the length fluid/cells had to travel through the catheter.  
 
We assessed if the optimized parameters were effective with the catheter by BES 
mBMSC onto 3D collagen-Glycosaminoglycan (CG) scaffolds, and allowing them 
to differentiate into chondrocytes. The results from this study indicated mBMSC 
remained fully functional and differentiated as normal after 21days on the scaffolds. 
To determine if the spray from the catheter was reaching the intended target site, 
differentiated chondrocytes were BES to a specific area on the scaffolds. Analysis 
showed chondrocyte staining only at the targeted area. These results also 
demonstrated huge potential for cartilage regenerative therapies. BES chondrocyte 
cells to an injured region using arthroscopy with this catheter can eliminate issues 
with immune rejection caused by scaffolds, or issues with the scaffolds themselves 
(mentioned above).  
 
Delivering specific number of MSC and/or other cell types directly to a specific 
tissue injury site, using the modified commercially available electrospray apparatus, 
with optimised parameters including low voltages, has revolutionised MSC delivery 
for therapeutic applications. This set up can potentially eliminate the complications 
associated with MSC entrapment, while limiting the need for artificial scaffolds in 
TE.  
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Introduction 
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1.1 Tissue Engineering and Regenerative Medicine 
The term “tissue engineering” (TE) emerged in the 1980’s by the US National 
Science Foundation’s (NSF), to identify proposals that sought to grow tissue in the 
laboratory. It was later expanded to the interdisciplinary approach of exploiting 
living cells to regenerate diseased, damaged or lost tissues inside a patient’s body. 
This also describes the initiatives for growing structures ex vivo for the purpose of 
drug discovery or diagnostics, or alternatively, that can then be re-implanted in order 
to replace tissues. In 1998 the term “regenerative medicine” (RM) was coined. This 
refers to the approach of re-establishing the structure and function of tissues and 
organs as opposed to the repair of damaged tissue (Baran et al., 2014).These terms 
are used interchangeably and occasionally together- (TERM).  
 
Traditional methods for replacing damaged tissue include the use of autografting and 
allografting. Autografting involves tissue transplantation from one part of the body 
to another within the same individual. This is regarded as the gold standard for 
treatment (Giannoudis et al., 2011). However, problems associated with this 
approach include lack of donor availability and risk of infection (Braddock et al., 
2001). Allografting involves the grafting of tissue obtained from a donor. However, 
various problems such as rejection by the patient’s immune system, donor tissue 
shortages, risk of infection and disease transmission from donor to patient and graft-
versus-host-disease, are indicative to such procedures (Younger and Chapman, 
1989). The gap between tissue/organ donors and recipients is becoming more 
expansive, which is primarily due to increased life expectancy. It has been reported 
that approximately 120,000 people died in 2010 from kidney failure, and 597,000 
died from heart disease, in the US alone (CDC.gov, cited 2014).  
15 
 
With the global market for TE estimated at $59.8 billion dollars and is expected to 
grow to $89.7 billion by 2016 (Research, B, cited 2014), the TE field aims to address 
these issues by developing new surrogates and strategies, as alternative treatments. 
One such substitute is the use of scaffolds on which cells can be grown. Typically 
three main requirements have been described for the development of a successful TE 
construct: (1) a biomaterial or scaffold that provides structural, morphological and 
biological cues, (2) growth factors or biophysical stimuli to direct cell growth and 
differentiation on the scaffolds and (3) cells to facilitate required tissue formation 
(Fig. 1.1). One particular cell type which has become synonymous with TE and cell 
therapy applications are Mesenchymal Stromal Cells. 
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Fig. 1.1 The tissue engineering triad. The three traditional requirements of a 
successful TE construct consisting of (a) cells, (b) biomaterials and (c) signalling 
molecules, adapted from O’Brien (2011). 
 
 
 
 
 
 
 
 
 
 
 
 
a 
b c 
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1.2 Mesenchymal Stromal Cells  
In 1966, murine mesenchymal stromal cells (MSC) were first discovered as a 
population of plastic adherent bone marrow cells, with the potential to differentiate 
into bone (Friedenstein et al., 1966). Castromalaspina et al. (1980) first isolated 
MSC from human bone marrow in 1980, with Caplan et al. (1991) coining the term 
mesenchymal stem cells over 10 years later.  This was based on the cells ability to 
differentiate into multiple cell types indicating their potential for regenerative 
medicine. Pittenger et al. (1999) were the first to demonstrate multilineage 
differentiation of MSC in vitro. However, in the following years as MSC failed to 
meet previously established criteria for stemness; “a long-term self-renewing cell 
that is capable of differentiation into specific, multiple cell types in vivo”; scientists 
became increasingly uncomfortable with the phrase “mesenchymal stem cells”. As 
the acronym coincided with the cells it had to be maintained, however “stem” was 
substituted for “stromal” to more accurately reflect the cell’s phenotype (Horwitz et 
al., 2005).  
 
MSC have undergone rigorous characterisation analyses to prove the cells isolated 
from tissue are specifically non-hematopoietic MSC. The cells ability to; adhere to 
plastic, provide adequate expression (or absence) of thirteen specific cell surface 
markers described by the International Society for Cellular Therapy (ISCT), and the 
execution of MSC tri-lineage differentiation into osteocytes, adipocytes and 
chondrocytes, have been scrutinised to confirm the phenotype of the isolated MSC 
population (Tropel et al., 2004; Dominici et al., 2006). 
 
18 
 
 In addition, MSC has become synonymous in suppressing T-cells proliferation in 
vitro (Di Nicola et al., 2002), while studies have also indicated that the cells migrate 
to injury sites and promote repair through the production of trophic factors, including 
growth factors, cytokines, and antioxidants (Chen et al., 2008; Karp and Leng 2009).  
Therefore thorough analyses of these abilities are also investigated for newly isolated 
MSC populations.  
 
Preliminary in vitro work has provided insights into MSC interactions with cells of 
both the innate and the adaptive immune system. MSC are vital in controlling the 
homeostasis of hematopoietic stem cells (HSC) in bone marrow, while maintaining 
their undifferentiated state. (Omatsu et al., 2010). With the exception of neutrophils, 
MSC have an inhibitory effect on immune cells, preventing activation and 
proliferation (Cassatella et al., 2011, Raffaghello et al., 2008).  In the bone 
parenchyma, MSC facilitate in maintaining an immunosuppressive environment, 
suppressing autoimmune reactions by maturing lymphocytes, until naive immune 
cells are released to the periphery (Dazzi et al., 2006). In addition, MSC demonstrate 
an immune privileged nature, meaning they express low levels of MHC class I and 
no MHC class II. This allows them to evade allogeneic reactions and NK killing 
(Grinnemo et al., 2004).  
 
The interaction between MSC and immune cells, coupled with easy isolation and 
culture ex vivo, makes MSC desirable candidates for cell therapy and tissue TE.  
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1.2.1 MSC as a Cell Therapy  
The cell therapy market was valued at $2.7 billion in 2011 and estimated to be worth 
close to $8.8 billion by 2016 (Syed and Evans, 2013). Studies introducing MSC 
within a broad range of experimental animal models including, multiple sclerosis 
(MS) (Zappia et al., 2005), type II diabetes (Lee et al., 2006), myocardial infarction 
(Lee et al., 2009) and critical limb ischemia (Lian et al., 2010), have reported 
positive therapeutic results. Advancements in MSC cell therapy has moved from 
exclusively lab based experiments, towards clinical and/or industrial environments. 
Analyses from phase II clinical trials for graft versus host disease (GvHD), type 1 
diabetes mellitus and chronic obstructive pulmonary disease (COPD), have 
demonstrated promising results when using MSC as a cell therapy for these diseases 
(Kebriaei et al., 2009; Mills, 2009). There are currently 308 ongoing MSC clinical 
trials, while FDA approval has been granted to use MSC in the treatment of MS 
(ClinicalTrials.gov).  
 
Although clinical trials have shown a number of promising results, there are 
challenges in using MSC. Excessive in vitro culture of MSC can lead to reduction in 
efficacy and senescence, unlike pluripotent stem cells (Katsara et al., 2011). One 
possible solution to this is the generation of MSC from inducible pluripotent stem 
cells (iPSC). These are genetically reprogrammed adult stromal cells that exhibit 
morphology, gene expression, proliferation and differentiation capacity similar to 
embryonic stem cells (Takahashi et al., 2007). A key advantage to using iPSC is 
their capability to replicate indefinitely. In addition, it has been reported that MSC 
differentiated from these cells keep this ability while still retaining characteristics of 
normal MSC (Gruenloh et al., 2011).  
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Although safety assessments are still being implemented for this novel cell type, 
iPSC may have potential in regenerative medicine, allowing for autologous, patient 
matched cell replacement therapy.  
 
1.2.2 MSC and Tissue Engineering applications 
MSC are found in multiple tissues, including bone marrow and adipose tissue, and 
have the potential to self renew and differentiate into numerous cell types including 
osteoblasts, chondrocytes, myocytes, adipocytes and fibroblasts (Pittenger et al., 
1999). Significantly for TERM purposes, human MSC (hMSC) can be readily 
isolated from the bone marrow of patients and as such are a clinically viable cell 
source. Furthermore, their relative abundance and accessibility makes hMSC 
attractive in comparison with neural stem cells and embryonic stem cells (Granero-
Molto et al., 2009). Importantly, hMSC can be directly implanted back to injured 
regions in the same patient, significantly reducing the possibility of transplant 
rejection. 
 
In their natural environment, stem cells reside within a “stem cell niche”. This is a 
unique tissue-specific microenvironment comprising numerous ECM proteins, 
polysaccharides and cytokines. Biophysical and biochemical signals provided from 
the ECM induce complex intracellular signalling pathways that regulate gene 
expression and ultimately cell differentiation (Ladd et al., 2011).  A major challenge 
when using MSC for TE is sufficiently recreating the stem cell niche environment. 
Therefore, the fabrication of functional three-dimensional (3D) constructs has 
become a vital component in TE field.  
21 
 
Some progress has been made regarding the biochemical signals required during 
stem cell differentiation (Lee et al., 2010; Li et al., 2013).   
 
However, the physical interactions between the cells and the ECM are also critical in 
directing cell fate. When developing 3D constructs, the ability to direct stem cell 
differentiation to the desired lineage is imperative. Failure to do so may lead to 
unexpected clinical consequences. The ability to combine several 
microenvironmental signals within a single scaffold is essential for achieving the 
ideal artificial stem cell niche design, that can control stem cell differentiation. In 
order to successfully recreate the stem cell niche and influence MSC behaviour in 
the desired manner, it is essential to understand the relationship between MSC and 
the fabricated 3D nanofibres.  
 
1.3 The role of Jetting Methodologies in Tissue Engineering and Regenerative 
Medicine 
Recent advances in TERM are due to the amalgamation of interdisciplinary fields, 
primarily biology with engineering. “Non-contact” placement of cells by jetting was 
originally introduced by the ink-jet (ink-jet printing: IJP) community. This 
technology was initially developed for the printing industry, but due to its ability to 
dispense controlled volumes of liquid, it was investigated as a non-contact process to 
direct the placement of cells onto surfaces. However, the technology itself negated 
several disadvantages. These included generating droplets which doubled in size 
once emitted from the needle. Also, increasing viscosity levels from particulate 
concentrations resulted in needle blockage, and finally the ink-jets had proven they 
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were incapable of generating fine residues with particulate based suspensions 
(Sanjan and Fuller, 2004).    
 
Laser guided cell writing (LGCW) was another technology investigated to distribute 
cells. This technology has several unique abilities specifically, it could emit single 
cells for controlled proximal placement (Pirlo et al., 2006). However, no viability 
studies examining the effect of lasers on cells were ever conducted, thus, leaving this 
technology much like ink-jets in a grey area.  
 
In addition to these methods, two jet-based methods that have received increasing 
attention are electrospraying and electrospinning. Briefly, electrospraying involves 
using tiny quantities of electrical charge that are transferred to a fluid as it passes 
through an emitter to generate a very fine spray of the fluid. This spray is finer, more 
controllable and significantly faster than aerosol (Jayasinghe et al., 2006).  
Electrospinning is a combination of electrospraying and dry spinning. Dry spinning 
involves dissolving a polymer in a solvent before spinning in warm air. As the 
solvent evaporates, the jet is elongated by a whipping process caused 
by electrostatic repulsion initiated at small bends in the fibre, and finally deposited 
on the grounded collector.
  
The elongation and thinning of the fibres resulted in the 
formation of uniform fibres (Li and Xia, 2004). This technology can fabricate 3D 
fibrous meshes with a varied range of fibre diameters from nanometer to micron size, 
mimicking the structure of natural ECM components such as collagen fibrils.  
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1.3.1 Electrospraying in Tissue Engineering and Regenerative Medicine 
Electrosprays are a physics phenomenon first observed by Gilbert in 1600’s. He was 
reported to have observed a droplet of liquid elongate and neck between a piece of 
amber, placed in contact with a resting droplet. This appeared to transform by 
increasing the spacing between the piece of amber, and the surface on which the 
droplet rested (Republished: Gilbert, 1991). Approximately 200 years later, Rayleigh 
(1878) investigated these observations further by applying a potential difference 
between a conducting capillary holding the flow of a liquid in the presence of an 
electric field. This was done with the aid of a grounded electrode. Many others have 
contributed to the understanding of these electrified “jets”, with recognition 
attributed to Zeleny (1914), Taylor (1964), Dole et al. (1968) and Fenn et al. (1998). 
The contributions made by these renowned physicists have led to ground breaking 
applications within the physical, chemical, engineering and more recently and life 
sciences fields. One such application was the development of electrospray ionization 
for mass spectrometry of large bio-molecules led by Fenn et al. (1998), which sees 
molecular characterisation for a wide range of applications within biology and the 
medical sciences (Fenn et al., 1998; Fenn et al., 2003). 
 
Electrosprays, which are a finer and more controllable aerosol, are initiated when a 
voltage is applied to a liquid. The charged liquid then passes through a conducting 
needle which is raised to a potential difference, with respect to a grounded electrode 
(Hayati et al., 1986). The potential difference between the electrodes provides an 
electric field which the charged liquid within the needle, enters. 
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 This is subsequently subjected to a multitude of forces which draw a column of 
liquid towards the grounded electrode, as illustrated in Fig. 1.2. During this process, 
a 3D cone is seen to form at the needle tip. Stemming from the cones apex is a jet of 
charged droplets, which then undergoes a break-up. This cone/jet is called a Taylor 
cone, so named after the physicist who discovered its generation (Taylor, 1964) 
(Fig.1.3). 
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Fig. 1.2 Schematic of an electrospray apparatus. Power supply applies voltage to 
a liquid, which passes through conducting needle towards a grounded electrode. 
Potential difference between conducting needle and ground electrode provides an 
electric field. Pump combined with electric field applies multiply forces which draws 
liquid towards grounded electrode, and subsequently collecting plate.  
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Fig. 1.3 Taylor cone. 3D cone forms at needle tip during successful electrospray. A 
jet of charged droplets stems from cone’s apex, which then undergoes a break-up, 
giving plume shape to droplets.  
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Electrospraying conditions such as jet stability and continuity, and jet break-up point 
and whipping, are governed fundamentally by three specific parameters. These 
include; (1) the apparatus set-up (the distance between the electrodes, needle 
configuration and shape of ground electrode), (2) liquid properties (electrical 
conductivity, viscosity, surface tension, density and permittivity), and (3) external 
atmospheric conditions (temperature and relative humidity (RH)) (Tang and Gomez, 
1996; Sullivan et al., 2007; Cloupeau and Prunet-Foch (1994); Jaworek and Krupa, 
1999). Various reports describe difficulties associated with all three parameters and 
are addressed in this project in relation to cell delivery (Chapter 3). 
 
In 2006, the Jayasinghe group was the first to report successful electrospray of a 
solution containing living cells, with no apparent deleterious effect on the cells 
(Jayasinghe et al., 2006 a, b). The term ‘bio-electrospray’ (BES) was coined to 
describe this technique. A range of cell types have been reported to have been 
successfully electrosprayed including primary cardiac cells (CC), mouse 
hematopoietic stem cells (mHSC), mouse bone marrow derived stem cells (mBMSC) 
and embryonic stem cells (ESC) (Abeyewickreme et al., 2009; Sahoo et al., 2010; 
Bartolovic et al., 2010; Ng et al., 2011; Guan et al., 2009; Ye et al., 2014).). Whole 
organisms such as nematode Caenorhabditis elegans were also reportedly BES with 
no obvious effects (Mongkoldhumrongkul et al., 2010).  
 
Electrospraying has also been used in conjunction with another methodology called 
electrospinning, to simultaneously electrospin polymers while electrospraying cells 
with the aim of improving cell penetration in 3D scaffolds (Stankus et al., 2007). 
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1.3.2 Electrospinning in Tissue Engineering and Regenerative Medicine 
Scaffolds are fabricated by various methods including solvent casting, particulate 
leaching, melt molding, rapid prototyping, phase separation, electrospinning and 
many others (Yang et al., 2001). Interest in the electrospinning process for TE 
applications has surged in the previous two decades, as it is a relatively simple, 
inexpensive process for scaffold fabrication. 
 
In constructing scaffolds for TE, it is preferable to provide cells with an environment 
which closely resembles their native ECM. Various scaffold fabrication techniques 
used in TE applications incorporate naturally derived materials such as collagen, into 
the scaffold. However, some methods such as melt molding require high 
temperatures which may denature proteins. In addition, Yang et al., (2001) 
demonstrated that solvent casting and particulate leaching provided scaffolds with 
very high porosity, but potentially low interconnectivity, which also interfered with 
the scaffold contour (Yang et al., 2001).  
 
Electrospinning nanofibers generate scaffolds which can mimic the ECM of many 
tissue types structurally, chemically, and mechanically (Ladd et al., 2001). In 
contrast to other scaffold fabrication methods, production of nanofibres by the 
electrospinning process provides excellent interconnectivity and control of porosity 
through fibre size adjustment (Pham et al., 2006). Porosity or “void fraction” is a 
measurement of “empty space” in a material. This interconnectivity can allow for 
integration of cells into the scaffold if the pore size is large enough, while also 
allowing for dissolution of soluble factors and nutrients through the scaffold (Ju et 
al., 2010). 
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Formhals published a series of patents from 1934 to 1944 describing an experimental 
setup for the production of polymer filaments using an electrostatic force (Formhals, 
1934; Formhals, 1940; Formhals, 1943; Formhals, 1944).  Since then, adaptations of 
this device have been created. In 1971, Baumgarten designed an electrospinning 
apparatus in which most current electrospinning devices are based. Acrylic fibres 
with diameters in the range of 0.05–1.1μm were electrospun by suspending the 
“spinning” from a stainless steel capillary tube. Fibre size was maintained by 
adjusting the feed rate of an infusion pump. A high-voltage direct current was 
connected to the capillary tube, whereas the fibres were collected on a grounded 
metal screen.  
 
Currently most electrospinning apparatus are built in-house. However the 
electrospinning principals remain the same as they rely on a high voltage from a 
direct (dc) or alternating current (ac) source, to charge a polymer solution or melt, 
contained in a syringe. Typically a polymer solution is used in TE to avoid high 
temperatures and additional equipment. Opposite the syringe is a grounded fibre 
collector. The charged polymer becomes attracted to the collector, and the polymer 
solution is pumped out at a controlled rate. At a critical voltage, charge build-up in 
the solution near the tip of the syringe leads to a self-repulsive force greater than the 
surface tension of the liquid. This causes the solution to erupt into four distinct 
regions as described below, which form a polymer current, terminating on the 
grounded collector. Polymer current releases its charge and forms solid polymer 
fibres (Reneker and Chun (1996).  
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The first region is the base where the polymer jet emerges from solution and tapers 
away to form the Taylor cone. This points in the direction of the grounded collector 
(Greiner & Wendorff, 2007). Following this, the jet negotiates the distance between 
the syringe and the collector and in which the polymer strand stretches, the solvent 
largely evaporates, causing the fibre diameter to decrease and solidify. The third 
region, often called the “splay” consist of a single rapidly whipping strand of 
polymer, which forms an opening spiral pattern as it approaches the collector. 
Finally the fourth region is the grounded collector where the polymer releases its 
charge and any remaining solvent evaporates, leaving only thin polymer fibres (Ladd 
et al., 2011) (Fig. 1.4). 
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Fig. 1.4 Schematic illustrating the electrospinning process. High voltage from a 
dc or ac source, charges a polymer solution or melt, contained in a syringe. Opposite 
the syringe is a grounded fibre collector in which the charged polymer becomes 
attracted. The polymer solution is pumped out at a controlled rate, and at a critical 
voltage, charge build-up in the solution near the tip of the syringe leads to a self-
repulsive force greater than the surface tension of the liquid. Solution then erupts 
into the four distinct regions. The first region is the base where the polymer jet 
emerges from solution and tapers away to form the Taylor cone. The second involves 
the jet negotiating the distance between the syringe and the collector and in which 
the polymer strand stretches. The solvent largely evaporates causing the fibre 
diameter to decrease and solidify. The third region, often called the “splay” consist 
of a single rapidly whipping strand of polymer, which forms an opening spiral 
pattern as it approaches the collector. Finally the fourth region is the grounded 
collector where the polymer releases its charge and any remaining solvent 
evaporates, leaving only thin polymer fibres on the grounded collector.  
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1.3.2.1 Electrospinning Parameters 
Electrospinning provides a wide range of controllable parameters making it 
beneficial when fabricating fibres. These parameters can be divided into three 
categories: processing parameters, solution parameters and ambient parameters.  
 
(1) Processing parameters include applied voltage, distance from the syringe to the 
collector (PD), needle gauge and shape, collector shape, flow rate, movement, and 
construction. Variation in these parameters is mostly due to the electrospinning 
apparatus being manufactured in-house. This has created major problems with 
reproducing results. Studies have shown that adjustments to increase or decrease the 
voltage, flow rate and/or potential difference, all resulted in unwanted beading 
developing on the fibres (Deitzel et al. 2001; Megelski et al. 2002; Doshi & 
Reneker, 1995). Thus, optimal conditions for electrospinning may vary between 
different polymer/solvent systems (Sill & von Recum, 2008).  
 
Scaffold geometry is essential in TE. This can be manipulated by altering the shape 
of the collector, in combination with rotational and translational movement. Flat 
electrospun mats are fabricated by spinning onto a flat collector, while tubular 
shaped constructs can be formed by spinning onto a cylindrically shaped collector 
undergoing rotational, and optionally translational, movement (Ladd et al., 2001). 
Fibres can also be electrospun in an aligned format which potentially can be useful, 
depending on the application (Theron et al., 2001; Xu et al., 2004). 
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(2) Solution parameters include polymer concentration, polymer molecular weight, 
solution conductivity, solution volatility, and solution surface tension. Polymer 
concentration is fundamental to the electrospinning process as it affects both fibre 
morphology, and other parameters such as surface tension (Sill & von Recum, 2008). 
A sufficient amount of polymer must be dissolved in the solvent in order for fibre 
formation to occur. It is essential for polymer strands to have sufficient chain overlap 
in order to physically link and form fibres. In general, increasing polymer 
concentration typically increases fibre diameter (Gupta et al., 2005). 
 
(3) Ambient parameters include temperature and relative humidity (RH). It has been 
observed that temperature may influence fibre diameter by changing the viscosity of 
the polymer jet (Pham et al., 2006). Humidity may potentially affect fibre 
morphology. In polymers which dissolve in aqueous solution, excessive humidity 
may prevent solvent evaporation (Ladd et al., 2011). Controlling these parameters in 
many common lab setting may prove difficult, leading to interference in producing 
consistent results.  
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1.4 Biomaterial properties essential for Tissue Engineering  
As aforementioned, electrospinning fibres is the predominant method used to 
fabricate 3D fibres. However, although the electrospinning process has shown 
potential and has existed over several decades, there is still a very limited 
understanding of this nanotechnology. One possible reason may be due to the wide 
variation in biomaterials used. To date, it is believed that nearly one hundred 
different polymer types have been successfully electrospun into nano or microfibers. 
 
Essential properties required when selecting a biomaterial for 3D scaffold fabrication 
include; providing sites for cell attachment, have the capability to develop porous 
and interconnected pore network for interaction with the host, while supporting cell 
migration, nutrient and waste movement, have strong mechanical stability, and 
initiates vascularisation by both seeded cells and the host tissue (Langer and Vacanti, 
1993). In addition, the ideal scaffold must possess a number of macro and 
microstructural properties to facilitate adequate tissue formation (Hutmacher, 2000). 
These properties are known to affect cell signalling, growth, survival, propagation, 
and differentiation. Cells must be able to adhere to and proliferate throughout the 
biomaterial before depositing a new matrix.  
 
In addition, fabrication of scaffold architecture and pore sizes are vital properties 
especially in bone and articular - cartilage repair. It is generally agreed that a highly 
porous, interconnected structure and a large surface area are conducive to cell 
infiltration as well as the diffusion of nutrients, oxygen and waste (Yannas, 2001). 
The ability to generate several pore sizes is essential due to cell size variation for the 
different cell types used in TERM applications. 
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 A smaller mean pore size leads to a higher surface area of the material allowing 
more cells to bind. However, large pores sizes are required to allow cell penetration 
and migration through the material (Yannas et al., 1989; O’ Brien et al., 2005; 
Murphy et al., 2010).  
 
The mechanical strength of the scaffold is another essential component which must 
be considered, especially in relation to repair of load-bearing defects. It is vital that 
scaffolds are capable of withstanding the hydrostatic pressures in vivo, especially 
with load-bearing tissue such as bone and articular cartilage. In addition, the rate of 
biodegradation should coincide with the rate of tissue formation in vivo. Scaffolds 
should function for a sufficient time frame pending on the length for the in-growing 
tissue to support itself, whilst replacing the degrading scaffold (O’ Brien, 2011).  
 
In vivo, scaffolds must induce minimum immune reaction so as not to impair healing 
or be rejected by the body. Biomaterials used in bone and cartilage TE fall into three 
primary categories including, synthetic bioceramics and, natural and synthetic 
polymers. These are designed into a variety of structures, including porous scaffolds 
for tissue repair. One such scaffold is based on the natural polymers collagen and 
glycosaminoglycans (GAG) named collagen-glycosaminoglycan (CG) scaffolds 
(Yannas et al., 1989). 
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1.4.1 Collagen-Glycosaminoglycan Scaffolds  
The addition of linear polysaccharides in the structure of GAGs has been reported to 
improve collagen function and regenerative abilities. GAGs are found within the 
natural ECM on cell surfaces, and are involved in cell-matrix interactions and wound 
healing. The most predominant GAG, chondroitin sulphate, is generally used in 
combination with a collagen, to fabricate scaffolds which can provide cells with an 
environment similar to the natural ECM. Therefore, cells tend to attach, migrate, 
infiltrate and differentiate on these scaffolds (Tierney et al., 2009). The concept of 
using crosslinked CG scaffolds (Fig. 1.5) was first introduced by Prof. Ioannis 
Yannas, to regenerate skin tissue (Yannas et al., 1989). This composite scaffold was 
later used for a number of other applications including nerve (Chamberlain et al., 
1989), bone (Farrell et al., 2006) and cartilage regeneration (Lee et al., 2003). Early 
studies have shown that CG copolymers degraded over extended periods of time 
when compared to GAG-free collagen polymers, which degraded rapidly. Therefore 
tissue formation and CG scaffold degradation coincided with that of the innate 
healing process (Yannas et al., 1975; Yannas and Burke, 1980). Crosslinking 
chondroitin sulphate with collaged fabricate scaffolds also enhanced mechanical 
properties, indicating these CG scaffolds are more advantageous than collagen alone 
scaffolds.  
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Fig. 1.5 3D Collagen-Glycosaminoglycan (CG) Scaffold with 325μm mean pore 
size. These spongy type scaffolds used as 3D in vitro model due to their fabrication 
from collagen and glycosaminoglycans. These are vital components of the natural 
ECM and crucial to wound healing in bone and articular-cartilage. Scale of CG 
scaffolds indicated by microscope slide measuring 22x50mm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 x 50mm 
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1.5 Cartilage Formation 
Cartilage is a strong, flexible and semi-rigid supporting tissue found in 
the joints between bones,  rib cage, ears, nose, bronchial tubes and the intervertebral 
discs. It forms the articulating surfaces of bones, and is a template for the growth and 
development of long bones, and fetal skeletons, which are eventually replaced by 
bone. In addition, cartilage can withstand compression forces, whilst maintaining the 
ability to bend. Cartilage is divided into three classifications: hyaline, fibrocartilage 
and elastic. The most common, hyaline, produces a glassy appearance to fibres. 
Fibrocartilage provides reinforcement with parallel bundles of collagen fibres, while 
elastic cartilage has elastic fibres as well as collagen fibres which are flexible and 
resilient (Messner and Gillquist, 1996). 
 
During chondrogenesis, cartilage is generated from immature chondroblast cells 
which mature into chondrocytes and secretes molecules that form the cartilage ECM 
matrix. The collagenous ECM secreted by chondroblasts is composed primarily of 
approx 10% aggrecan, 75% water, and a mix of collagen and GAG fibres and a host 
of macromolecules. Collagen Type II fibers are responsible for giving the future 
cartilage matrix its very high tensile strength (Asanbaeva et al., 2008; Pearle et al., 
2005). Proteoglycans generate the swelling pressure responsible for shielding the 
matrix from stress of compression loading. These attach themselves to up to 100 
molecules of chondroitin sulphate and up to 50 keratan 
sulfate glycoaminoglycan chains, which bind to one molecule of hyaluronic acid 
(HA) (Asanbaeva et al., 2008).  
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As the chondroblasts secrete matrix and fibres, they become entrapped and embed 
themselves in the cartilage matrix, maturing into chondrocytes (Van Osch et al., 
2009). Chondrocytes are the only cells found in healthy cartilage. 
 
1.5.1 Articular-Cartilage and Lesion formation  
The thin ends of mammalian synovial joints are lined with a layer of articular 
cartilage, which allows two opposing skeletal rudiments to facilitate the transfer of 
forces between them and their practically frictionless movement. In addition it acts 
as a weight absorber during sustained static loading (Hunzike, 1992). Synovial joint 
are considered an organ due to their various mechanisms, with the articular-cartilage 
layer as one functional component. Articular-cartilage is a highly sophisticated 
tissue. The structural and physiological properties of this layer affiliates with the 
synovial fluid, the synovial membrane, the subchondral bone-plate and the 
subchondral bone-marrow, as well as with the trabecular bone and its vascular 
system (Fig 1.6). Both positive and negative influences such as cell recruitment from 
synovial membrane and cartilage erosion respectively, on articular-cartilage repair 
are generally related to this highly-vascularized tissue-compartments (Hunziker and 
Rosenberg, 1996 and Bromley and Woolley, 1984). From the beginning of the 20th 
century it was suggested that if articular-cartilage lesions penetrate the layer of 
subchondral bone and the bone-marrow spaces a “spontaneous repair” reaction will 
occur. This involves filling these spaces with blood consisting of diverse 
chondroprogenitor cells and fibrin, which then acts as a supportive, blood clotting 
scaffold, with limited healing responses (Shapiro et al., 1993; Altman et al., 1992). 
However, this repaired tissue is only functional for a few months (Jackson et al., 
2001; Dell’accio and Vincent, 2010).  
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In addition, even if the repaired tissue persists for longer periods of time, the tissue 
function remaining ineffective (Metsaranta et al., 1996; Schmitt et al., 2014).  
Despite these poor results, current surgical treatments still use this spontaneous 
repair reaction, in clinical use today. These are classified as “bone-marrow-
stimulation” approaches (Buckwalter and Brown, 2004). 
 
Articular-cartilage lesions are defects that rarely heal, or in some instances, partially 
heal under certain biological conditions. Symptoms such as joint pain, joint-locking 
phenomena and reduced or disturbed joint function are indicative of these lesions. It 
has been reported that the size of the articular-cartilage lesion does not impact on the 
seriousness of the symptoms such as joint pain (Jones, 2013; Haviv et al., 2013). 
Moreover, the lesion progression is generally believed to lead to the onset of 
osteoarthritis (OA). In western countries, OA is one of the most common diseases 
suffered by elderly people. Primary OA is a disabling joint disorder where origins in 
individual cases, although multifactorial, are usually unknown. However, OA can 
also be triggered by physical injury such as sports or occupational accidents and is 
known as secondary OA (Buckwalter and Mankin, 1997; Gilbert, 1998; Madry et al., 
2011).  
 
The underlining mechanisms of OA are still relatively unknown, however, age and 
obesity are primary risk factors associated with this disease. Life-expectancy and 
youth obesity are both steadily increasing, resulting in a more prevalent disease 
(Chaganti and Lane, 2011). Characteristics associated with early stages of this 
disease include structural defects such as fibrillation of the cartilaginous layer and 
loss of proteoglycans.  
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These are confined to the articular-cartilage layer and do not penetrate the 
subchondral-bone plate. Such lesions do not heal spontaneously and broaden and 
lengthen over time. Therefore, what is initially an isolated condition progresses into 
a crippling disease, with larger joints such as the knee, hip and shoulder being most 
frequently affected (Grenier et al., 2013; Aigner  and Soder, 2008; Hunziker and 
Rosenberg, 1996; Kim et al., 1991). Once the process is initiated, lesion growth is 
progressive and no prophylactic or medical interventions can prevent it. Similarly, 
there are no effective biologically-based treatments available to induce healing of the 
structural defects (Lefkoe et al., 1993; Gratz et al., 2008; Hunziker and Stahli, 2008; 
Simon and Aberman, 2009).  This is due to the tissues structure and physiology such 
as the fact that the cartilage in avascular, aneural and is lightly populated with 
chondrocytes (Hunziker et al., 2002; Quinn et al., 2013). Chondrocytes are reported 
to slowly respond to internal and external stimuli under pathological conditions, 
when lesions develop in vivo. They demonstrate limited proliferation abilities, with 
reduced potential for the de-novo synthesis of an ECM (Hunziker and Rosenberg, 
1997; Shapiro et al., 1993; Hunziker, 2002). 
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Fig. 1.6. Schematic drawing of a normal synovial joint. The structural properties 
of a synovial joint with articular-cartilage layer connected with the synovial cavity, 
the synovial membrane, subchondral bone-plate and subchondral bone-marrow. 
Reproduced from Hunziker et al., (2014). 
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1.5.2 Cartilage Regenerative Therapy 
In 1959, a technique by Pridie introduced the drilling of holes through injured 
articular-cartilage layer into the subchondral bone-marrow spaces. This is surgical 
treatment which exploits the spontaneous repair response by a “stimulation of the 
bone marrow” which is based upon surgically-induced bleeding from the 
subchondral-bone spaces, and subsequent blood-clot formation (Insall, 1974; Muller 
and Kohn, 1999, Insall, 1967). Various other surgical approaches including abrasion 
chondroplasty and microdrilling use similar methods (Kim et al., 1991; Altman et 
al., 1992; Hoemann et al., 2007; Chen et al., 2009). However, analyses from these 
surgical techniques indicate that these methods are highly inconsistent with non-
reproducible results. In addition, the tissue that is formed is a fragile fibre, with a 
limited functional time-scale (Chen et al., 2009). Therefore the necessity for new and 
improved cartilage therapies was apparent.  
 
In 1989, Grande et al developed a new technique named autologous-chondrocyte 
implantation (ACI) in a preclinical study with rabbits. However, it wasn’t until 1994 
that Brittberg et al. introduced this technique into to the clinical orthopaedic field. 
ACI involves arthroscopically harvesting a biopsy of healthy articular cartilage from 
a low- or a non-load-bearing location of the diseased joint. The cartilaginous tissue is 
then enzymatically digested to release chondrocytes and are subsequently expanded 
in culture. A suspension of the cultured autologous chondrocytes is introduced 
directly into the defect, beneath a surgically-sutured periosteal flap, which is usually 
removed from the medial tibia (Fig. 1.7). Systems involving the application of 
freely-suspended cells are technically more complex than those in which matrix-
embedded cells are grafted.  
44 
 
This is due to the careful placement and suturing of periosteal flaps, required to 
retain the cells and provide optimal integration with the surrounding articular-
cartilage. However, it has been reported that these flaps can become dislodged 
during the postoperative recovery period if joint movement is not restricted. 
Therefore, consequences of flap displacement are the loss of the implanted cells 
(Driesang and Hunziker, 2000). More recently, a matrix associated variant of the 
ACI method (MACI), was introduced (Jones et al., 2008). This involves embedding 
the autologous chondrocytes within a matrix such as collagen or hyaluronan, instead 
of suspending them in a fluid. This potentially eliminates issues with periosteal 
bioincompatibility, inflammation and degradation. However, an appropriate carrier 
has not yet been developed thus far, and remains the focus of this type of research.  
 
One disadvantage to the ACI method is that it involves a minimum of two surgeries 
resulting in costly process, with long-term patient planning. In addition, extra lesions 
are created within the joint during the harvesting of healthy cartilage which may 
contribute to the development of OA (Lee et al., 2000; Hjelle et al., 2002). It has 
been suggested that the chondrocytes may be removed from osteoarthritic rather than 
healthy articular cartilage, or even from other tissue sources (Dehne et al., 2009; 
Giannini et al., 2005). For cartilage therapies, ACI is the predominant technique, 
although its superiority to other methods including microdrilling has not been 
proven. Moreover, a study by Knutsen et al. (2007) indicated that there was no 
advantage in using ACI method compared to microdrilling, in patients with 
cartilaginous lesions in the femoral condyle. 
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 This was a 5-year trial clinical trial and although it is suggested that the repaired 
tissue for ACI is structurally superior to that laid down after microdrilling, 1 year 
after treatment the clinical outcome was the same for both methods (Saris et al., 
2008). One possible explanation is that the biological and biomechanistic properties 
for both treatments are basically the same. During the ACI application the defected 
floor and walls of are usually “neatened” by shaving, which induces local bleeding 
and a spontaneous repair response from the bone-marrow spaces.  
 
Both microdrilling and ACI have proven clinically ineffective in patients over 50 
years of age. This is possibly due to the microdrilling method which involves the use 
of hBMSC, and the transplanted autologous chondrocytes suffering age-related 
losses in their potential to proliferate and differentiate (Zheng et al., 2007). This 
demonstrates the lack of effective cell-based repair strategies especially for elderly 
persons, who are particularly prone to osteoarthritic lesions of the articular-cartilage 
layer.  
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Fig 1.7.Schematic representation of the ACI technique. A fragment of articular 
cartilage is removed from the periphery of the joint that bears the lesion. This 
fragment of tissue is digested to release the chondrocytes, which are grown in vitro 
for up to 21 days. A periosteal flap is then removed from the medial tibia and sutured 
over the lesion. A suspension of the expanded chondrocytes is injected beneath the 
flap into the lesion. Reproduced from Hunziker et al., (2014). 
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1.6 Objectives 
The overall goal for this research was to develop an alternative cell delivery strategy 
for TERM and cell therapy purposes. Specifically, this study aimed to investigate 
whether the jetting methodology BES, can be improved upon to deliver various cell 
types at low voltages. Issues with reproducing data between experiments were 
addressed by the introduction of a commercial bench-top electrospray apparatus and 
gold standard parameters. In addition, studies into the effects BES had on cellular 
and immunological characteristics of mBMSC following electrospraying at low 
voltages were also examined. Furthermore, investigations focused on whether BES 
mBMSC and BES chondrocytes were viable and functional following electrospray, 
using a specially designed medical catheter and gold standard parameters on CG 
scaffolds. Results suggested a 3D representation of possible in vivo applications and 
indicated if BES process of cells can be promoted from “bench to beside”. 
 
Fundamentally, the objective for this research was to refine the BES jetting 
methodology to electrospray MSC and/or various cell types, in order to provide an 
alternative strategy for cell delivery. 
 
The specific aims of this thesis were: 
1) To establish reproducible gold standard parameters and cell solutions compatible 
with the design of a commercial electrospray apparatus, to BES mBMSC at low 
voltages, as a cell delivery method (Chapter 3) 
 
48 
 
2) To generate new polymer mixtures and establish gold standard parameters 
compatible with same commercial electrospray apparatus for the fabrication of 
unique 3D scaffolds, for future cell delivery method (Chapter 4) 
 
3) To investigate the full effects the BES process had on the cellular and 
immunological characteristics of mBMSC, at low voltages (Chapter 5).    
 
4) To investigate BES mBMSC and BES chondrocyte on CG-scaffolds using gold 
standard parameters and specially designed commercial catheter to (1) demonstrate 
viability and function of the cells post BES (2) to demonstrate spray emitted from 
catheter needle is controlled and cells directly reach a targeted site (3) to give more 
comprehensive results to challenge current therapies either for MSC or cartilage 
specific therapies, with the addition of CG scaffolds (4) to demonstrate advancement 
in the BES process towards an alternative cell delivery system with the addition of 
catheter, as it fits all types of endoscopes for application through key hole surgery 
(Chapter 5) 
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Chapter 2 
Materials and Methods 
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2. Methods  
 
2.1 Ethical Approval 
All procedures involving animals were carried out by licensed personnel. Ethical 
approval for all work was received from the ethics committee of Maynooth 
University (Ref: BSRESC-2012-015)  
 
2.2Animal Strains 
The following mouse strains were used: BALB/c and C57/BL6 (Charles River Lab 
Manston Rd, Margate, UK). All mice were housed in accordance with EU Directive 
2010/63/EU, regulated by the Health Products Regulatory Authority and used with 
ethical approval. Sample sizes for animal experiments were determined by statistical 
power calculations.  
 
2.3 Tissue Culture 
 
2.3.1 Cell Lines 
The human adenocarcinoma cell line, A549, was obtained from the European 
collection of cell cultures (ECACC). The human bronchial SV-40 transformed cell 
line, BEAS-2B, was obtained from the American Type Culture Collection (ATCC). 
Cells were routinely cultured in culture medium consisting of a 1:1 mixture of 
DMEM: Hams-F12 medium supplemented with 5 % fetal bovine serum (FBS)  and 2 
mM Lglutamine (L-glut) (all components for medium from Gibco, Paisley, UK). 
Cells were maintained at 37 ºC in a humidified atmosphere of 5 % carbon dioxide 
(CO
2
). Experiments were carried out within eight passages. 
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2.3.2. Sub-culture 
Cell lines were sub-cultured upon reaching 80 %-100 % confluency. Culture medium 
was removed from the flask and cells were washed with 5 ml PBS. 0.5 % trypsin-
EDTA (Gibco) solution was added to the flask and incubated at 37 ºC until the cells 
had detached (not exceeding 20 min). At this point, an equal volume of serum-
containing medium was added to the flask and the entire contents were transferred to 
a 30 ml sterilin and centrifuged at 259 x g for 5 min in a bench-top centrifuge. The 
supernatant was discarded and the pellet was re-suspended in fresh culture medium. 
Cells were used to either re-seed the tissue culture flask or for experimental set up. 
 
2.3.3. Cell Freezing 
Cells were periodically frozen and stored in liquid nitrogen to maintain cell stocks. 
Cells at 50-70 % confluency were ideal for freezing (i.e. they were in the log phase 
of growth and actively dividing). Freezing medium consisting of a 9:1 ratio of FBS: 
DMSO (Sigma-Aldrich, Wicklow, Ireland) was first prepared and protected from 
light. Cells were trypsinised as described above and the resulting pellet was re-
suspended in 500 μl FBS. Dropwise 500 μl freezing medium was added to the cell 
suspension using a Pasteur pipette and the entire volume (1 ml) was then transferred 
to a cryovial and stored on ice. Cryovials were initially placed at -70 ºC for no longer 
then two weeks before being transferred to liquid nitrogen for long term storage. 
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2.3.4. Cell Thawing 
DMSO can enter living cells and quickly freezes thus preventing crystal formation 
within the cell at reducing temperatures. However, at room temperature this 
chemical is toxic to cells. Culture medium (1:1 DMEM/F12, 5 % FBS, 2 mM L-glut) 
was prepared initially and 10 ml was added to a sterilin prior to thawing of cells. The 
cryovial was removed from liquid nitrogen and kept on ice. Cells were thawed by 
placing cryovial in a 37 ºC water bath. On thawing cells were quickly transferred to 
the sterilin containing 10 ml culture medium (1:1 DMEM/F12, 5 % FBS, 2 mM L-
glut) and spun at 259 x g for 5 min. Pellet was re-suspended in culture media and 
entire volume was transferred to a tissue culture flask and placed in a 37 °C 
incubator humidified with 5 % CO2. Culture medium was changed 8 – 17 hrs later to 
remove any excess DMSO and dead cells. 
 
2.3.5. Cell Counting 
Cells were trypsinised, spun at 259 x g and re-suspended in an appropriate volume of 
culture medium. A haemocytometer (Sigma-Aldrich) was used onto which a glass 
coverslip was fixed. Approximately 10 μl of the cell suspension was allowed flow 
between the haemocytometer and the coverslip by capillary action to fill the upper 
chamber. Cells contained within each of the four 16 corner squares were counted and 
an average obtained. This count was representative of the total number of cells x 10
4
 
/ml of the original cell suspension. In order to determine cell viability, cells were 
stained with Ethidium Bromide Acridine Orange (EBAO) (0.025 mM Ethidium 
Bromide, 0.027 Acridine Orange) (Sigma-Aldrich) at a 1:1 ratio of cell suspension to 
EBAO solution. The EBAO stained cell suspension was counted by similar means as 
described above using a UV microscope.  
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Viable cells were labelled with the cell permeable Acridine orange and fluoresced 
green under UV light. Non viable cells were labelled with Ethidium bromide and so 
emitted an orange fluorescence. 
 
2.3.6 Isolation and Culture of Murine Bone Marrow-Derived MSC  
Six - eight week old female BALB/c or C57BL/6 mice were sacrificed by cervical 
dislocation. Femurs and tibias were dissected and the surrounding muscle removed. 
Murine BMSC (mBMSC) were isolated and expanded using modifications of 
methods previously described (Peister et al., 2004; English et al., 2007). 
Modifications included flushing out bone marrow using specialised mesenchymal 
stem cell medium ‘Mesenchymstem’ (GE Healthcare Life Sciences, 
Buckinghamshire,UK). Isolated cells (6.0-6.5×10
7
) were suspended in 
mesenchymstem containing 10µg/mL penicillin/streptomycin (pen/strep) (Gibco) in 
T75 flasks and incubated in hypoxic conditions (5% O2). Non-adherent cells were 
removed after 3 hours. The flasks were washed with sterile PBS after 24 and 48 hr 
and incubated for 3 weeks until colonies of fibroblast-like cells appeared. Cells were 
passaged by trypsinisation with 0.2mM trypsin / 1 mM EDTA (Invitrogen-Gibco) 
for 2 minutes at 37°C. Cells were centrifuged (400 x g, 5 min) and re-seeded at 5-6 × 
10
6
 cells in T75 (passage 1).  Passage 2 cells were cultured in mesenchymstem 
media, 10µg/mL pen/strep and 1ng/mL murine basic fibroblast growth factor (bFGF) 
(Peprotech, Rocky Hill, NJ,US). Passage 3 cells were cultured in expansion medium 
(cα-MEM medium) consisting of Minimum Essential Medium Alpha medium 
(Gibco) supplemented with 10% (v/v) heat inactivated FBS (Gibco), 10% (v/v) 
equine serum (Hyclone laboratories, Logan, UT), 10µg/mL pen/strep, 10µg/mL L-
glut (Gibco) and 1ng/mL murine bFGF in T-175 flasks.                
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Cells were maintained in either hypoxic (5% O2) (passage 1-3) or normoxic (21% 
O2) (passage 4-10) conditions. Surface marker expression, multilineage 
differentiation and T-cell suppression assay was carried out as described below to 
ensure that MSC were not contaminated with hematopoietic or other cell 
contaminants, and that cells retained differentiation capacity as previously described 
(English et al., 2007). Cells were used between passages 3–10. 
 
2.4 Commercial Jetting Apparatuses and Optimisation Parameters 
 
2.4.1 Bio-Electrospray Apparatus and Optimisation 
The ‘Generation 1’ BES instrument was purchased from AVECTAS (Dublin, 
Ireland) and consisted of a voltage supply, double syringe pump, a single extrusion 
needle (30 gauage) configuration, lab jack, camera, laser and ring-shaped ground 
electrode. Working in a dark, non-sterile environment, A549 cells ranging from 1 x 
10
6 
and 6 x 10
6 
cells/ml, suspended in either PBS or PBS+0.5M EDTA (Sigma-
Aldrich) (Table 1)  liquid solutions, were delivered using the syringe pump via a 1ml 
syringe to the extrusion needle. The conductivity of the PBS and PBS+0.5M EDTA 
saline solutions was measured at 13.5 and 15.5 (mS/cm) respectively using a 
conductivity metre (Mettler Toledo, Ireland). An electric field was applied to the 
needle to draw the cells into jets and deposit them in droplets into 6-well or 24-well 
sterile tissue culture plates. Sprays were illuminated with the laser and photographs 
were taken with the camera 1 frame per second over 5 seconds in order to determine 
when a continuous, stable Taylor cone was achieved. Voltages of 1, 2, 3, 4, 5 and 
6kV were tested and distances and flowrates were varied.  
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It was established the optimum conditions for electrospraying A549 cells with this 
device used voltages between 3-6kV, which varied depending on the relative 
humidity (RH), flow rate at 5µL/min and potential difference (PD) of 22mm. Exact 
same parameters were applied when BES mBMSC in cα-MEM culture medium. 
Conductivity level recorded for this cell solution was at 22.18mS/cm using the 
conductivity meter. 24-well plates were used to collect cells for studies examining 
BES mBMSC viability and pro-reparative properties. BES mBMSC were collected 
in 6-well plates for differentiation studies, while mBMSC electrosprayed into 96-
well plates were examined for immunodulatory studies.  
 
2.4.2 Electrospinning Apparatus and Optimisation   
The ‘Generation 1’ BES instrument (AVECTAS) consisting of a voltage supply, 
double syringe pump, a single extrusion needle configuration, lab jack, camera, laser 
and ground electrode, was used to electrospin polymer fibres. Modifications to the 
apparatus included changes in needle gauge and ground electrode shape. The needle 
gauge changed from 30 to 23 gauge and ground electrode was modified from a ring-
shape to rectangular-shape approx 300mm in length. Working in a non-sterile 
environment, voltages varied between 7-9kV, depending on RH, and charged the 
polymer solutions contained in a 5mL syringe. The rectangular-shaped ground 
electrode was placed opposite the single conducting needle at an optimum PD of 
24mm, where an electric field drew the charged polymer solutions towards the 
grounded electrode. The polymer solution was pumped out at an optimal controlled 
rate of 3μL/min and at a critical voltage (~7-9kV). Once the charge from the polymer 
was released, forms of solid polymer fibres were observed for various polymer 
blends.  
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As with BES optimisation various, flowrates, PD, and voltages were tested to 
establish the optimal parameters mentioned.   
 
2.4.3 SprayCell™ Apparatus and Optimisation 
The SprayCell™ BES catheter device containing a 30 gauge single needle was 
obtained from AVECTAS, Dublin, Ireland. The catheter was attached to the 
electrospray apparatus described above and used to BES mBMSC. Parameters 
remained the same as the electrospray apparatus described above except for the 
flowrate which was 10μL/min. Voltage remained at 6kV irrespective of RH. Final 
optimal parameters for this apparatus were, flowrate at 10μL/min, voltage applied at 
6kV, PD of 22mm using 30 gauge single needle. 
 
2.5 Cell Viability from various commercial Electrospray Apparatus  
 
2.5.1 Viability of mBMSC post Bio-Electrospray with Spraybase
®
 
1 x10
6
 electrosprayed mBMSC were re-suspended in 5mL PBS supplemented with 
1% (v/v) FBS (FACS buffer). 5 µL of 7-amino-actinomycin D (7-AAD) Staining 
Solution (e-Bioscience, San Diego, CA, US) was added, the cells were incubated for 
15 minutes at 4°C and then analysed by flow cytometry (FACS Accuri, California, 
USA) using CFlowPlus software (BD Biosciences, Oxford, UK).  
 
2.5.2 Viability of mBMSC post Bio-Electrospray with SprayCell™ 
1 x 10
6 
BES mBMSC were re-suspended in FACS buffer, stained with 7-AAD 
staining solution, incubated for 15 minutes at 4°C, and analysed using flow 
cytometry, as described above. 
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2.6 Spray Consistency and Control 
 
2.6.1 Measurement of Consistency of Electrospray Delivery 
 
3.5 x 10
6
 mBMSC were suspended in 300µL cα-MEM medium and BES at a flow 
rate of 5 µL/min. Three 100 µL fractions were collected sequentially in 3 separate 
wells of a 24 well plate. These cells were immediately harvested and counted using a 
haemcytometer and Olympus CK40 Light Microscope (Olympus, Germany). 
 
2.6.2 Control of Spray from Needle tip 
1x10
6 
mBMSC/mL were BES onto commercially bought polyethylene 
Alvetex
®
Scaffold disc (AMS Biotechnology Ltd., Abingdon, UK).  Cells were 
stained with 500 μL Methylene Blue solution (Sigma-Aldrich) and 500 μL Neutral 
Red stain (Sigma-Aldrich), and incubated at room temperature for 5 minutes. 
Scaffolds were washed x3 times with PBS (2 ml/well) for cells stained with neutral 
red, and a further x2 times for cells stained with Methylene Blue. After the last PBS 
wash, scaffolds were placed onto a 22 x 50mm microscope glass slide where either a 
circular shape of electrosprayed mBMSC (Methylene Blue) or semi-circle shape of 
BES mBMSC (Neutral Red) were observed. mBMSC BES onto scaffold disc and 
stained with Neutral red were also observed using brightfield imaging under 
Olympus CK40 Light Microscope (Olympus) at x4 magnification.  
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2.7 Polymer Mixtures and Electrospun Polymer Fibres 
 
2.7.1 Fabrication of PEO/PEG/agarose fibres  
4mL PEO, 2mL PEG and 2mL agarose, all dissolved in dH2O (all Sigma-Aldrich) 
were blended together using a magnet stir bar and a hot-plate magnetic-stirrer device 
(Nordic Scientific, Sweden), in a 10mL sterlin for 15 minutes. PEO/PEG/agarose 
fibres were electrospun from this polymer mixture using optimised parameters, 
flowrate at 3μL/min, applied voltage ~7-9kV and a PD of 24mm. Similar results 
were seen for polymer blends of 30%w/v PEO, 50%w/v PEG and 100%w/v agarose 
dissolved in dH20 (Sigma-Aldrich) at ratios 1: 0.4 :0.6 and 1: 0.5 :0.5. 
 
2.7.2 Fabrication of PEO/collagen/cα-MEM fibres 
Modifications to manufactures protocol for commercial 3D Culture Matrix™ Rat 
Collagen I were made (AMS Biotechnology Ltd). Specifically, 98mL of cα-MEM 
culture medium was added to 2mL of 3D Culture Matrix RGF BME, to give a final 
concentration of 2%, in 100mL duran bottle. This was lightly swirled to mix and 
incubated at 37°C for 30 minutes. 6mL of PEO dissolved in dH2O, was blended with 
1mL of 2% collagen I, and 1mL of cα-MEM, using magnetic stir bar and magnetic 
stirrer device (Nordic Scientific) for 15 minutes. Polymer mixture had appropriate 
viscous consistency to successfully electrospin PEO/collagen/cα-MEM fibres at 
optimal parameters (Flowrate - 3μL/min, Voltage - ~ 7-9KV, PD – 24mm). 
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2.7.3 Fabrication of PEO/agarose/cα-MEM fibres 
6mL of PEO dissolved in dH2O, was blended with 1mL of agarose dissolved in 
dH2O, and 1mL of cα-MEM, using magnetic stir bar and magnetic stirrer device 
(Nordic Scientific) for 15 minutes. PEO/agarose/cα-MEM fibres were then 
electrospun using optimal parameters of flowrate at 3μL/min, applied voltages of ~ 
7-9KV and PD at 24mm, in combination with suitable viscosity levels from polymer 
mixture. 
 
2.8 Characterisation of mMSC pre- and post- Bio-Electrospray 
 
2.8.1 Surface Marker Detection on mBMSC 
BES mBMSC were harvested, washed in sterile PBS and re-suspended in FACS 
buffer to yield approximately 1 x 10
5
 cells/4 ml polypropylene FACS tubes (Falcon, 
BD Biosciences). Fluorochrome conjugated antibodies (Table 2) or isotype controls 
were incubated with cells for 15 min at 4 °C. Cells were then washed in 2 ml FACS 
buffer, vortexed and centrifuged (300 x g, 5 min). The supernatant was removed and 
cells were re-suspended in 200 mL FACS buffer. Cells were then analysed by flow 
cytometry. 
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2.8.2 Osteogenic Differentiation of mBMSC 
1 x10
6
 mBMSC/mL were BES, harvested, and seeded at a density 5 x 10
4
 cells/mL 
into a 6-well plate and incubated at 37 °C, 5% CO2. Once confluent, typically after 
3-4 days, cells were incubated for 21 days in osteogenic differentiation medium 
containing α-MEM, 1mM dexamethasone (Sigma-Aldrich, Dublin, Ireland), 20mM 
β-glycerolphosphate (Sigma-Aldrich), 50μM L-ascorbic acid-2-phosphate (Sigma-
Aldrich), 50ng/ml L-thyroxine sodium pentahydrate (Sigma-Aldrich). The medium 
was then removed and cells were fixed in 10 % (v/v) neutral buffered formalin for 20 
min at room temperature. After several washes in PBS, cells were incubated for 20 
min in 1 ml of 1% (w/v) Alizarin Red S Stain. Cells were then washed with dH2O. 
For visualisation, 1 ml of dH2O was added to each well and cells were examined 
under the microscope.  
 
2.8.3 Adipogenic Differentiation of mBMSC 
1 x10
6
 mBMSC/mL were BES, harvested, and seeded at a density 5 x 10
4
 cells/mL 
into a 6-well plate. Once confluent, cells were incubated for 21 days in adipogenic 
differentiation medium consisting of α-MEM, 5.0μg/ml insulin in 0.1N acetic acid 
(Sigma-Aldrich), 50μM indomethacin (Sigma-Aldrich), 1μM dexamethasone 
(Sigma-Aldrich), 0.5μM 3-isobutyl-1-methylxanthine (IBMx) in methanol (Sigma-
Aldrich). Cells were fixed in 10 % neutral buffered formalin for 20 min at room 
temperature, washed in PBS, stained with 1 ml of 0.5% (w/v) Oil Red O Isopropanol 
fat differentiation stain and examined using a microscope.  
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2.8.4 Chondrogenic Differentiation of mBMSC 
1 x10
6
 mBMSC/mL were BES into a 24-well plate, immediately harvested and 2 x 
10
5
 BES mBMSC were centrifuged (300 × g, 5 min) in a 15 ml polypropylene tube. 
The pellet was cultured in 500 μl chondrogenic medium and incubated in normoxic 
incubator. The chondrogenic medium consisted of α-MEM, 100nM dexamethasone, 
50μg/ml ascorbic-acid-2-phosphate (Sigma, Dublin,Ireland), 40μg/ml proline 
(Gibco), 1mM sodium pyruvate (1:99) ITS + supplement (Gibco), 10ng/ml TGF-
β3(Peprotech). Fresh medium was added every 3-4 days for 21 days, after which the 
pellet was washed with Dulbecco’s PBS. Total RNA from cells growing in a 15ml 
tube was isolated using TRIZOL Reagent (Invitrogen-Life Technologies). RNA was 
DNase treated (Invitrogen-Life Technologies) and reverse transcribed using 
Superscript® III Reverse Transcriptase (Invitrogen-Life Technologies).  PCR 
products were separated by agarose gel electrophoresis and visualised using GelRed 
Nucleic Acid Stain (Biotium, Cambridge, UK) using Quantity One software version 
4.4.1 (Biorad, Hemel Hempstead, Hertfordshire, UK). Target transcripts were 
amplified using primers for Collagen 2a and Aggrecan (Sigma) and GAPDH 
(Eurofins) (Table 3). 
 
2.9 T-Cell Suppression Assay  
BES mBMSC were seeded at 1.5x10
4
/mL in a 96-well plate in 100µl of cα-MEM 
and incubated overnight. The next day, splenocytes were isolated from the spleens of 
two MHC mismatched mice (BALB/c and C57/BL6). The re-suspended pellets were 
stained with carboxyfluorescein diacetate succinimidyl ester (CFSE) Proliferation 
Kit (CellTrace™, Life Technologies, Dublin, Ireland) using a previously described 
method (Quah and Parish, 2012).  
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Briefly, splenocyte pellets re-suspended in 1mL RPMI 1640 (Invitrogen-Gibco) 
supplemented with 5% FBS were placed in 15mL polypropylene tubes and laid 
horizontally. 110µL of PBS was placed at the top of the 15mL tube, ensuring the 
PBS and the pellet did not mix. 1.1µL of 5mM CFSE (CellTrace™) was added to the 
PBS. The solutions were then quickly inverted and vortexed to mix the cells and 
CFSE together. The tube was covered with foil and incubated for 5 minutes at room 
temp. 10mL 20°C PBS containing 5% FBS was added and centrifuged (300 × g, 5 
min). The pellets were then re-suspended in 1mL RPMI 1640 supplemented with 
10% (v/v) FBS, 10µg/mL pen/strep, 10µg/mL L-Glut. Splenocytes were seeded at 2 
x 10
5
/well and incubated for 72 hr. On Day 5, splenocytes were transferred to 96 
well V-bottom plates (Corning Inc., NY, USA), centrifuged (950 × g, 5 min) and 
supernatant was discarded. Cells were washed with 100 µL FACS buffer, 
centrifuged (950 × g, 5 min) and supernatant was discarded. 0.3 µL CD3-APC (e-
Bioscience), 0.3µL 7-AAD and 2.4 µL FACS buffer were added to each well and 
plates were incubated at 4°C for 15min. Cells were washed again with 200µL FACS 
buffer, centrifuged (950 × g, 5 min) and supernatant was removed. 100µL FACS 
buffer was added to each well and splenocytes were analysed by flow cytometry. 
 
2.10 Scratch Assay  
A549 or BEAS-2B cells were seeded at 5 x10
4 
cells/well in culture medium 
(Dubeco’s Modified Eagles Basal Medium (DMEM-F12) (Gibco, Paisley, UK), 5% 
FBS, 2 mM L-Glutamine) into the lower chambers of a 24-transwell plate. After 24 
hr, a P200 pipette tip was used to scratch a line through the confluent monolayer of 
A549 or BEAS-2B cells in each well to make a wound. Either pipette mBMSC, BES 
mBMSC or control media was added to the transwell inserts.   
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After 24 hr, the A549 or BEAS-2B cells were fixed with 500µL of 10% formalin at 
room temp for 20 min and then stained with 1% crystal violet dye (Sigma, Dublin, 
Ireland) at room temp for 20 min. Plates were washed five times with PBS and cells 
were examined using a microscope. The width of the wound was measured at the 
top, middle and bottom of each well and an average width was determined for each 
well.  
 
2.11 Bio-Electrospray of Differentiated Bone and Fat cells  
mBMSC were seeded at 2 x 10
5
/well in 6-well culture plates, and differentiated into 
osteogenic and adipogenic lineages as described in section 2.8.2 and 2.8.3 
respectively. At day 21, cells were typsinised, suspended in 1mL cαMEM and BES 
into 6-well plates. Voltage and flowrate remained at ~3-6 kV depending on RH and 
at 5µL/min respectively. PD changed from 22mm to 25mm. 2mL cαMEM was 
added to each well and incubated for 24hr. The BES cells were stained with either 
Alizarin Red S Stain (bone differentiation stain) or Oil Red O Isopropanol (fat 
differentiation stain), and examined under the microscope for red deposits 
(osteogenesis) or orange/red fat globules (adipogenesis). 
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2.12 Bio-Electrosprayed mBMSC/Chondrocyte on Collagen-Glycosaminoglycan 
Scaffolds using SprayCell™ Apparatus 
 
2.12.1 Collagen-Glycosaminoglycan (CG) Scaffold Fabrication 
CG scaffolds were fabricated as described by O’ Brien et al. (2004) using a freeze-
drying process. Briefly, a Ultra Turrax T18 Overhead blender (IKA Works Inc., 
Wilmington, NC) was used to blend a suspension of 0.5% microfibrillar bovine 
tendon collagen and 0.044% shark-derived chondroitin-6-sulfate in 0.05M acetic 
acid. This was done at 15,000 rpm at 4°C for 3hr, “degassed” under a vacuum of 
50mTorr for 1hr, to remove all the air bubbles created from the mixing process. The 
resultant, known as slurry, was frozen to a temperature of -10°C, at a constant 
cooling rate. The scaffolds were then crosslinked and sterilised using a 
dehydrothermal process at 105°C for 24hrs in a vacuum oven at 50mTorr (VacuCell 
22, MMM, Germany) post freeze-drying, to make a CG co-polymer graft. 
 
2.12.2 Immunofluorescence and Confocal of mBMSC on CG-Scaffolds 
CG-scaffolds containing BES mBMSC were placed into inserts of 12 well transwell 
plates. Inserts were covered with 650 µL cα-MEM medium with 1200µL medium 
added to lower chamber. After 24hr cells were methanol fixed to scaffolds. The 
medium was removed and scaffolds were rinsed x3 with PBS. Ice cold methanol was 
added to wells and scaffolds were placed at -20 ºC for 5 min. The methanol was 
removed and cells were allowed air dry for approximately 15-20 min. Following air 
dry, cells were used immediately. BES mBMSC were stained with 10μL DAPI 
nuclear stain (300 nM in PBS) and 10μL MitoTracker Red mitochondrial stain (500 
nM in methanol).  
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Scaffolds were mounted in DPX mounting medium (BDH) onto 22x50 mm 
microscope slides and covered with a coverslip. Fluorescently tagged stains were 
examined using an Olympus IX81 fluorescent microscope (Mason Technologies, 
Dublin, Ireland) where camera and microscope settings (exposure time, brightness 
and light intensity) were kept constant for examining both DAPI and MitoTracker 
Red stained BES mBMSC.  
 
Similarly, BES mBMSC were methanol fixed to CG-scaffolds, with scaffolds then 
mounted to microscope slides as described above. Following this, confocal 
microscopy was used to analyse cell distribution through the scaffold with Olympus 
FluoView™ (Olympus, Germany) after 24hr incubation.  
 
2.12.3 Chondrogenic Differentiation of mBMSC post Bio-Electrospray on CG-
Scaffolds  
2 x 10
5 
mBMSC were BES onto CG-scaffolds and placed into inserts of 12 well 
transwell plates. Inserts were covered with 650 µL chondrogenic medium and 
1200µL of medium was added to lower chamber followed by incubation for 21 days. 
Cells were then fixed with 10% formalin for 24hrs and scaffolds were processed for 
Toluidine Blue O (Sigma) staining. This was done using an automated processor 
(Shandon Pathcentre, Runcorn, UK) which immerses the scaffolds in fixatives and 
sequential dehydration solutions, including ethanol (70%, 80%, 95% x 2, 100% x 3) 
and xylene (x 2) (BDH AnalaR® Laboratory Supplies Poole, UK).  
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Scaffolds were then embedded in paraffin wax using the Shandon Histocenter 2 
(Shandon) and left to set overnight at 4 °C. 5μm sections were cut using a microtome 
(Shandon Finesse 325, Thermo-Shandon, Waltham, MA, USA), placed on 
microscope slides and incubated at 56 °C for a minimum of 1 h. Slide sections were 
immersed in two changes of xylene for 10 min each, following by re-hydration in 
three decreasing concentrations of ethanol (100% x 2, 95% and 80% v/v) for 5 min 
each, then placed in two changes of water to rinse off excess xylene. Sections were 
stained with Toluidine Blue O for 2 min and washed with dH20. Finally, slides were 
subjected to a series of dehydration steps in ethanol (80%, 95% and 100%) for 5 min 
each, mounted with DPX mountant (BDH) and examined under a light microscope. 
 
2.12.4 Bio-Electrospray of Differentiated Cartilage cells on CG-Scaffolds 
mBMSC were seeded at 2 x 10
5
 into in a 15 ml polypropylene tube and 
differentiated into chondrocytes as described in section 2.8.4. At Day 21, the pellet 
was broken up using a pestle and mortar, re-suspended in 1mL cαMEM and 
electrosprayed onto CG-scaffolds at voltages 6kV. Cells were incubated in 
undifferentiated medium for 24hr, fixed and processed for Toluidine Blue O staining 
as described in section 2.12.3. 
 
 
 
 
 
 
 
67 
 
2.13 Statistical Analyses 
Statistical analysis was performed using GraphPad Prism software (GraphPad, San 
Diego,CA).  Paired t-test was used when statistical analysis was required between 
two experimental groups.  One way ANOVA was used to test for statistical 
significance of differences when multiple experimental groups were compared with 
post hoc tukey.  Data are presented as the ± standard error of the mean (SEM).  P-
values of p<0.05 (*), p<0.01 (**) or p<0.001 (***) were considered statistically 
significant. 
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  Table 1: A549 Saline Cell solutions                                                                                                                                                       
  
Buffer Components Concentration Supplier 
PBS Sodium chloride 0.137 mol Oxoid (Ireland) 
 Potassium chloride 0.003 mol Oxoid (Ireland) 
 
Disodium hydrogen 
phosphate 
0.008 mol Oxoid (Ireland) 
 
Potassium dihydrogen 
phosphate 
0.0015 mol Oxoid (Ireland) 
PBS+EDTA Sodium chloride 0.137 mol Oxoid (Ireland) 
 Potassium chloride 0.003 mol Oxoid (Ireland) 
 Disodium hydrogen 
phosphate 
0.008 mol Oxoid (Ireland) 
 Potassium dihydrogen 
phosphate 
0.0015 mol Oxoid (Ireland) 
 EDTA 0.5 mol Qiagen (Ireland) 
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      Table 2: Antibodies used for flow cytometry analysis 
 
Antibody 
 
Fluorochrome 
 
Isotype 
 
Supplier 
CD 11b FITC Rat IgG2b eBioscience 
CD 34 FITC Rat  IgG2a eBioscience 
CD 44 PE Rat IgG2b eBioscience 
CD 45 PE Rat IgG2b eBioscience 
CD 73 PE Rat IgG1 eBioscience 
CD 86 PE Rat IgG2a eBioscience 
CD 90.2 FITC Rat IgG2b eBioscience 
CD 105 PE Rat IgG2a eBioscience 
CD 106 FITC Rat IgG2a eBioscience 
CD 117 FITC Rat IgG2b eBioscience 
Sca-1 PE Rat IgG2b eBioscience 
MHC Class l FITC Mouse IgG2a eBioscience 
MHC Class ll PE Rat IgG2b eBioscience 
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Table 3: RT-PCR Chondrocyte primers 
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Chapter 3 
Optimisation of commercial electrospray apparatus 
and the establishment of optimal bio-electrospraying 
parameters 
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3.1 Introduction 
In 2006, Jayasingh et al. integrated physics, engineering and biology to develop a 
technique named “bio-electrospraying”. This involves applying a voltage to a liquid 
solution of living cells and dispersing them through a controllable spray. This is an 
innovative cell delivery method for TERM purposes. However, although a number 
of cells including various stem cells were reported to have been successfully 
electrosprayed, a number of key issues have not been addressed. These issues 
include the lack of a non-universal electrospray apparatus resulting in a wide 
variation in parameters applied to electrospray cells, which adversely affects the 
ability to reproduce data between experiments. The apparatus design, specifically the 
needle and electrode configuration significantly influences both establishment of a 
Taylor cone and the various parameters used. This study addresses these issues by 
employing a commercial bench-top electrospray apparatus to establish a set of “gold 
standard” parameters to accompany the apparatus. Therefore, applying these 
parameters in conjunction with the commercial electrospray will establish a method 
to reproduce data between experiments. 
 
To date, previous studies described building in-house electrospray apparatuses, 
modifying the systems to accommodate their experimental design. All electrospray 
devices include a power supply, pump, needle, ground electrode and collecting plate 
(Fig. 1.2). The key differences reported in several apparatuses were the type of 
needle configuration and ground electrode construct used.  Needle configuration can 
either include a single or coaxial needle, whereas electrode geometry refers to ring, 
plate or point-shaped electrodes. These components directly influence the 
establishment of a stable, continuous Taylor cone.  
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Jayasingh et al. (2006 a&b) and Odenwalder et a.l (2007) were unsuccessful when 
they attempted to BES cells in suspension using a single needle configuration. In 
their studies jurkat cell line in a saline solution, and primary rabbit aorta smooth 
muscle cells (RASMC) or porcine vascular smooth muscle cells (PVSMC) in a 
polydimethysiloxane (PDMS) medium, were electrosprayed through a single needle 
respectively.  Both studies reported similar results such that, an unstable and volatile 
spray of cell suspension intermittently emitted from the needle tip.  Cell viability 
analyses recorded high percentages in cell death for these studies. As a result both 
groups opted to use a coaxial needle for the remainder of their investigations.  
 
A coaxial needle consists of incorporating one needle within another, 
accommodating cells in the inner needle, and a gas or medium in the outer 
needle. Sheath gas is predominantly used in BES studies. This is a gas that is 
discharged through a tube that is coaxial with the electrospray emitter to 
pneumatically assist the formation of the sprayed droplets. Pneumatic systems are 
commonly powered by compressed air or compressed inert gases (Murray et al., 
2013). This introduces extra parameters to this type of electrospray system including 
gas flowrate and compressed pressure measurements, which also requires 
optimisation for each in-house electrospray apparatus. Therefore, the introduction of 
more variables significantly increases problems associated with reproducing data 
between experiments. Hence, optimising a single needle configuration, where cells 
in solutions emit from one needle, eliminates issues with extra parameters which 
adversely affect replicating data. This is also more cost effective, due to less 
equipment required for the electrospray apparatus.  
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In addition, coaxial needles have separate needles for cells and gas/medium, 
therefore the formation of spray emitted remains the same. However, since both cells 
and solution are BES through one needle diameter when using a single needle, 
variations in cell numbers can effect spray formation, generating various types of 
sprays and/or jets (as shown in this chapter, Fig 3.6). Adjusting spray formation may 
prove beneficial to future electrospraying applications either in vivo or in vitro.  
 
Ground electrodes have varied in geometry between different labs, as its shape is 
designed for the sole purpose of in-house experiments. This inevitably impacted on 
the optimum parameters used to BES cells, between the different labs. Jaysingh et al. 
(2006) used a copper collecting plate with a large circumference, resulting in using 
voltages ~ 10kV and flowrates of 10
-7
 to 10
-12
 m
3
 s-
1
 to electrospray their cell 
suspensions. Whereas Odenwalder et al. (2007) choose a ring-shaped ground 
electrode placed in a culture well and BES their cell solution at 7kV. Where in 
flowrates for the study was between 10
-7
 to 10
-12
 m
3
 s-
1
. Neither study stated exact 
figures for flowrates, giving only approximates, indicating flowrate may have 
fluctuated within experiments. In addition, Odenwalder et al. (2007) reported using 
PD of 15mm for their investigations, whereas Jayasinghe et al. (2006 a,b) described 
varying PD between 18 – 22mm depending on the study. Both the ring and plate 
configurations encourage the development of a diverging droplet spray, resulting in a 
similar electrospray (Jayasinghe et al., 2003). However, the parameters used to 
achieve the Taylor cone with the different apparatus varied between each study.  
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Applied voltage, PD, flowrate needle gauge, viscosity and electrical conductivity of 
cell solutions are vital in BES living cells. Differences in these parameters suggest 
there is no universal set of optimal parameters for electrospraying.  Sahoo et al. 
(2010) BES mBMSC between 7.5 -15kV, where as Ye et al. (2014) applied voltages 
of 10kV when electrospraying human adipose-derived stem cells (hADSC). For 
both studies difficulties with low viscosity were overcome by adding high 
numbers of cells to the suspensions, 1 x 10
6
 cells/mL. However, it is known that 
living cells have high ion concentrations which inadvertently lead to the 
generation of high conductivity levels. Although a coaxial needle was used in 
these studies, it was never fully explained by either Sahoo et al. (2010) or Ye et 
al. (2014) how the groups overcame this problem, using their in-house 
electrospray apparatus. Odenwalder et al. (2007) in contrast demonstrated how 
they overcame problems associated with high ion conductivity and low 
viscosity, using the coaxial needle configuration. The inner needle contained 
PVSMC or RASMC cells, and the outer needle was filled with unique medical 
grade silicone PDMS oil. This medium has a very low electrical conductivity,  
with high viscosity levels eliminating the issues connected with these 
parameters.  
 
As each in-house constructed electrospray apparatus has its own specific parameters 
applied, this leads to a significant problem with reproducing results between 
experiments. The primary aim of this study was to overcome issues with 
reproducing data by using a commercially available electrospray device, 
Spraybase
®
 procured from AVECTAS, to develop a set of “gold standard” 
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parameters. Possessing a commercial apparatus with universal parameters will 
permit replication of data between experiments.  
 
Secondly, this chapter focused on BES cells at low voltages, and generating cell 
suspensions compatible with Spraybase
®
 electrospray. High external electric 
fields have been proven to be detrimental to cells. They induce pore formation within 
cell membranes and/or internal heat damage to cells, resulting in cell death and 
function (Gass and Chernomordik, 1990; Ho and Mittal, 1996; Chen et al., 1998). 
Hence, BES cells at the lowest possible voltage was a vital overall aim of this study.  
Spraybase
®
 is designed with a ring-shaped electrode in conjunction with single 
needle configuration. Therefore, designing new cell solutions compatible with the 
electrospray of cells in a suspension through a single needle was imperative. 
Determining viscosity and conductivity properties of these new solutions was 
critical, so not to interfere with the establishment of a stable Taylor cone, for the 
BES of cells. The A549 cell line was used for optimization purposes for both 
parameters, and cell suspensions. These optimal parameters were proven 
reproducible with this commercial device, when they were applied to electrospray 
mBMSC primary cells. This study concluded with investigations demonstrating the 
accuracy of the cell spray to a target area for this apparatus, where in cells can be 
directed and/or aligned depending on the study, without spray settling at 
unintentional areas. Furthermore, Chapter 5 demonstrates the importance of spray 
control in promoting our overall aim, employing BES method as alternative strategy 
for MSC delivery in TERM.  
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3.2 Design of the commercially available electrospray apparatus - Spraybase
®
 
A typical electrospray apparatus was assembled incorporating a power supply, a 
pump, conductive single extrusion needle, ground electrode and collecting plate. 
Spraybase
® 
is a commercial electrospray equipped with a 30 gauge single needle 
configuration, ring-shaped ground electrode, camera and laser. The inclusion of 
laser and camera allowed for accurate results to demonstrate when a continuous, 
stable Taylor cone was achieved. Unlike conventional in-house built electrospray 
devices, Spraybase
® 
is a purpose built power supply is certified to EU IEC safety 
standards. This makes it safe to operate in any environment, lab or medical (Fig. 
3.1). 
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Fig. 3.1 Configuration of electrospray set-up. (A) ‘Generation 1’ BES instrument 
supplied by AVECTAS.  The instrument comprised a syringe pump, which delivered 
cell suspensions to a single extrusion needle, charged by IEC standard approved 
power supply unit, with laser and camera. (B) Ring-shaped ground electrode in well 
of a 24-well tissue culture plate.  
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3.3 Achieving a bio-electrospray of A549 cells in suspension using the single 
needle configuration and ring ground electrode design at low voltages 
Given the single needle/ring-shape electrode arrangement for the Spraybase
®
 
apparatus, initial studies involved determining if it was possible to generate a stable 
electrospray of cells in solution, using this system. A549 cells suspended in different 
saline solutions were used to examine several needle gauges, at various potential 
differences, flowrates, voltages, temperature and RH. Table 4 demonstrates the 
conditions favourable with a successful electrospray of cells in suspension and are 
highlighted in red. Those shown in black indicate the parameters examined but 
cannot produce a stable, continuous Taylor cone of cells. It was found that 
temperatures above 30°C and RH over 50% significantly influenced BES occurring. 
Therefore, those highlighted in red where further analysed to determine optimal 
parameters to BES A549 cells in saline solutions. 
 
Using the laser and camera combination for visualization, the optimised parameters 
for a stable Taylor cone and spray of A549 cells were recorded at; flowrate 5μL/min, 
30 gauge single needle and PD of 22mm, once temperature and RH remained below 
30°C and 50% respectively. It was also determined high RH resulted in an automatic 
higher voltage range i.e. 43% RH determined voltage started between 4.5 – 5kV The 
most significant result from this study demonstrated cells were BES at voltages 
measuring between ~ 3-6kV, depending on temp and RH. This signifies the lowest 
voltages recorded to date for the BES of cells using an electrospray device, 
regardless whether it’s single or coaxial needle configurations (Fig. 3.2).  
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Table 4: Summary of parameters wherein an electrospray of A549 cells occurred 
(red) and the parameters examined but unsuccessful in BES A549 cells (black) in 
saline solutions using single needle configuration and ring-shape electrode.  
 
 
Flowrate 
(μL/min) 
 
Voltage 
(kV) 
 
Single 
Needle 
(Gauge) 
 
Potential 
Difference 
(mm) 
Temperature 
(°C) 
Relative 
Humidity 
(%) 
3 2.69 23 17 15.6 29.6 
5 3.32 27 19 17.5 36.5 
10 3.48 30 20 18.5 41.6 
15 4.25 32 22 19.4 43.6 
20 4.69  23 20.0 45.9 
 4.78  24 20.1 48.2 
 4.98  25 20.6 50.2 
 5.36   22.5 53.3 
 5.49   23.8 55.2 
 5.87   25.3 56.2 
 6.00   28.0 60.7 
 6.25   29.5  
    30.8  
    32.1  
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Fig. 3.2 Taylor Cone achieved using single needle configuration and ring-shape 
electrode. BES A549 cells in saline solution established and maintained stable 
Taylor cone (white box), when using the single needle configuration and ring 
electrode components of Spraybase
®
.  Red hue from the laser, in combination with 
the camera gives visual confirmation of the electrosprayed cells in solution. Optimal 
parameters included flowrate at 5μL/min, voltages between ~ 3-6kV (depending 
RH), 30 gauge single needle at potential difference of 22mm. 
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3.4 Saline-based cell solutions were compatible with commercial electrospray to 
bio-electrospray A549 cells  
In addition to determining optimal parameters to BES A549 cells, establishing cell 
suspensions compatible with the single needle/ring electrode configuration were 
simultaneously investigated. Viscosity and electrical conductivity are influenced by 
the chemical and physical properties of solutions, and have been shown to interfere 
with Taylor cone stability when using single needle configurations. As the 
commercial electrospray includes a single needle, solutions were developed for 
compatibility with the device, cell survival and counteracting problems associated 
with viscosity and conductivity. 
 
Saline solutions such as PBS and PBS supplemented with 0.5M EDTA have low 
conductivity and are none toxic to cells. For these reasons, 1x 10
6
 A549 cells/mL 
were added to PBS and PBS+0.5M EDTA, and investigated as possible cell 
suspensions for BES with the commercial apparatus, at optimized parameters. The 
addition of such high cell numbers was to overcome problems associated with low 
viscosity. 
 
BES A549 cells in solutions of PBS and PBS+0.5M EDTA, allowed formation of a 
stable Taylor cone, using the single needle/ring electrode arrangement. After 24hrs, 
brightfield imaging demonstrated that A459 cells which were in the two solutions 
adhered to the plastic culture wells following electrospray. Cell proliferation was 
evident for both cell suspensions due to the presence of daughter cells observed in 
the culture wells. Cell morphology for each suspension of electrosprayed cells 
resembled that of the pipette control (Fig. 3.3).   
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In addition, it appeared that there was a higher cell number present in culture wells 
containing BES A549 cells in PBS+0.5M EDTA solution, compared to BES A549 
cells in PBS. This is possible due to the chelating agent EDTA which prevents 
clumping of cells, permitting fewer blockages within the needle, and allowing for a 
more improved electrospray.  
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Fig. 3.3 Brightfield images of BES A549 cells in PBS and PBS+0.5M EDTA 
solutions. (A) Pipette A549 cells growing in culture (control). (B) 1 x 10
6
 BES A549 
cells/mL suspended in PBS after 24hr. (C) 1x10
6
 BES A549 cells/mL suspended in 
PBS+0.5M EDTA after 24hrs. Both electrosprayed A549 cell suspensions adhered to 
the plastic culture wells and demonstrated similar morphology to control. BES cells 
also demonstrated cell division was evident as daughter cells were observed. Cell 
numbers appeared higher in culture well containing BES A549 cells in PBS & 0.5M 
EDTA. Parameters for both included flowrate 5μL/min, voltages of ~ 3-6kV 
(depending  RH), using 30 gauge single needle at PD of  22mm.  
 
 
 
 
 
 
 
A 
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3.5 Bio-electrospray of mBMSC using optimised parameters 
The previous studies established optimal parameters to BES A549 cells in saline 
solutions, which are compatible with single needle/ring electrode configuration of 
Spraybase
®
 electrospray apparatus. Subsequently, the following studies addressed 
the significant problem with reproducing results by employing the optimised 
parameters to BES mBMSC, in saline solutions, using the commercial electrospray. 
 
mBMSC were isolated and cultured as described previously (Chapter 2- Section 
2.3.6). These cells were then BES using established optimal parameters including 
flowrate at 5μL/min between voltages of ~3-6 kV (depending RH), using 30 gauge 
single needle at PD of 22mm. Similarly, 1x 10
6
 mBMSC cells/mL were BES to 
negate low viscosity issues for both PBS and PBS+0.5M EDTA saline solutions.  
 
mBMSC were successfully BES using optimal parameters. Brightfield imaging 
demonstrated the BES mBMSC adhered to the plastic culture well after 24hr, for 
both solutions. This vital characteristic associated with MSC indicated the electric 
field from the voltage did not affect the cells in these suspensions, post electrospray. 
mBMSC morphology for the electrosprayed cells resembled that of pipette control 
cells. However, the number of mBMSC present in the well after 24hr for both PBS 
and PBS+0.5M EDTA appeared low (Fig. 3.4).  
 
mBMSC are substantially larger cells than A549 cells, and it was hypothesised that 
the cells were too big to emit from the small needle gauge. Therefore the effect of 
needle size was examined. However, the results remained the same for various 
needle gauges such as 23, 27, 30 and 32 gauge.  
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Adjusting flowrates and/or increasing the cell numbers in suspension (6x10
6 
cells/mL) also resulted in similar findings, and the number of BES mBMSC 
observed in the wells remained considerably low. 
   
Therefore, having eliminated the possibility that the optimised parameters influenced 
the quantity of mBMSC sprayed, the effect of cell solution on BES mBMSC 
numbers was carried out. Using the original parameters, 5μL/min, 30 gauge needle, 
22mm PD and voltages of ~3-6kV (depending on RH),  mBMSC in cα-MEM culture 
medium were bio-electrosprayed. Brightfield images revealed a significant increase 
in BES mBMSC present in the wells after 24 hr.  These cells adhered to the wells 
and demonstrated mBMSC morphology similar to their pipette control (Fig. 3.5). 
Further analysis demonstrated on three separate days, approximately 80 x 10
4
 ± 
1.7%, 82 x 10
4
 ± 1.9% and 80 x 10
4
 ± 0.7% of original 1 x 10
6
 mBMSC/mL in 
solution, BES into the wells suggesting a high yield of mBMSC were 
electrospraying using this apparatus at optimal parameters (n-3) (Fig. 3.5 C).   
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Fig. 3.4 Brightfield images of BES mBMSC cells in PBS and PBS+0.5M EDTA 
solutions. (A) Pipette mBMSC cells growing in culture (control). (B) BES mBMSC 
suspended in PBS after 24hr. (C) BES mBMSC suspended in PBS & 0.5M EDTA 
after 24hr. BES mBMSC adhered to the plastic culture wells for both cell 
suspensions after 24hr,  indicating vital cellular characteristics was unaffected by 
voltage. BES mBMSC maintained similar morphology to pipette control. Cell 
numbers appeared low for BES mBMSC in both wells. Parameters for both included 
flowrate 5μL/min, voltages of ~ 3-6kV (depending RH), using 30 gauge single 
needle at PD of 22mm.  
                                                   
 
A
  
B
  
C
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Fig. 3.5 Brightfield images of BES mBMSC cells in cα-MEM medium. (A) 
Pipette mBMSC cells growing in culture (control). (B) BES mBMSC suspended in 
cα-MEM culture medium. Increased quantity of mBMSC appeared to have 
electrosprayed when submerged in cα-MEM culture medium. mBMSC morphology 
for both BES and pipette cells appear similar. In addition, cell adhesion, a vital 
characteristic associated with MSC, remained unaffected by the applied voltage, as 
cells adhered to the plastic culture wells, after 24hr. It was suggested the nutrients in 
the cell solution which increased cell survival while suspended in solution between 
experiments. Parameters included flowrate 5μL/min, voltages of ~ 3-6kV (depending 
RH), using 30 gauge single needle at PD of 22mm.  
.  
 
 
 
 
B
  
A
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Fig. 3.5 mBMSC count immediately post electrospray. (C) 1 x 10
6
 mBMSC/mL 
were BES into three wells of 24-well plate using flowrate of 5μL/min, 30 gauge 
single needle, 22mm PD and voltages ~3-6kV on three separate days. The cells were 
immediately harvested from the wells and counted using a haemocytometer. 
Approximately 80 x10
4
 ± 1.7%, 82 x10
4
 ± 1.9% and 80 x10
4
 ± 0.7% mBMSC were 
counted post BES. This indicated a high volume of mBMSC were electrospraying 
into the wells (n-3).   
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3.6 Diverse jet-modes established at low voltages when bio-electrospraying 
mBMSC 
Jet-based technologies involve charging liquid solutions to several thousand volts, 
passing through a large-bore needle to divide into droplets (Eagles et al., 2006). By 
definition an electrosprayed liquid solution or polymer is only achieved when a 
continuous, stable Taylor cone is generated.  
 
Two distinctive types of electrospray, plume spray and cone-jet mode, were 
generated when mBMSC suspended in cα-MEM culture medium were BES using 
Spraybase
®
 apparatus (Fig. 3.6 A & B). While both sprays maintained continuous, 
stable Taylor cones, the spray formation changed with different cell numbers.  1 x 
10
6
 mBMSC /mL in cα-MEM culture medium electrosprayed into a “plume” shape, 
covering a large area of the culture wells. Whereas, 3 x 10
6
 mBMSC/mL in cα-MEM 
culture medium, electrosprayed a cone-jet configuration generating a central 
ligament of cells. Due to the high cell numbers, mBMSC were forced together in the 
jet mode, which directed all cells to a smaller, more specific area of the well. 
Significantly, voltages were maintained between ~3-6kV regardless of spray mode.  
 
mBMSC electrosprayed at ~10kV using Spraybase
®
 generated volatile, unstable 
sprays and occasional sparking was observed under these conditions. The cell 
suspension was ejected intermittently from the needle and dispersed to various parts 
of the well (Fig. 3.6 C). Viability assays proved difficult to carry out due to the 
limited numbers of cells present in the well after 24 hours. Several BES mBMSC 
were found floating in the wells indicating their adherence capabilities had been 
seriously affected by the high voltage.  
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In addition, brightfield images demonstrated mBMSC morphology was circular in 
shape instead of long, spindle- fibroblasts after 24hr (Fig 3.7 A). Cell debris was also 
found scattered throughout the culture wells indicating cell membranes had burst 
resulting in cell death, presumably from the high voltage applied during the spray 
(Fig 3.7 B).       
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Fig. 3.6 Spray modes achieved with electrospray set-up. mBMSC suspended in 
cα-MEM culture medium were BES at different voltages to achieve desired 
jet/spray. (A) Jet mode involving 3 x 10
6
 mBMSC/mL with central ligament of cells 
visible. (B) plume spray of 1 x10
6 
mBMSC/mL. Both jet and spray achieved at 3-
6kV (depending on RH), flowrate of 5µL/min, PD of 22 mm, internal diameter of 
syringe 1.457mm and 30 gauge single needle. (C) Unstable jet/spray of 1 x 10
6 
mBMSC/mL at 10kV intermittingly emitted cell suspension from the needle. All 
photographs were taken 1 frame/second for 5 frames. 
 
Key: (i) Needle for (A) (B) (C) (ii) Taylor cone for (A) & (B) and intermittent 
emitted cells for (C) (iii) (A) jet mode with central ligament of cells (B) plume spray 
(C) 24-well plate (iv) 24 - well plate for (A) & (B).         
Jet mode - 3 x 106 mBMSC/mL BES with central ligament of cells at ~3-6kV 
Plume spray – 1 x 106 mBMSC/mL BES at ~3-6kV 
Unstable jet/spray intermittently emitting 1x 106 mBMSC/mL at 10kV 
A 
C 
B 
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Fig 3.7 Brightfield images of BES mBMSC at 10kV. 1 x 10
6
 mBMSC/mL were 
BES at 10kV, flowrate of 5µL/min, PD of 22 mm, resulting in (A) circular 
morphology and (B) cell debris scattered throughout culture well. This indicated the 
cell membranes burst during electrospray process at 10kV, resulting in non-viable 
BES mBMSC. 
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B 
94 
 
3.7 High yields of viable mBMSC were continuously distributed when bio-
electrosprayed at low voltages  
Analyses using viability exclusion assay determined if BES mBMSC were affected 
by the low voltages used in these studies. mBMSC viability for both pipette, and 
electrosprayed cells, were determined using 7-AAD staining assay and flow 
cytometry. Analysis at day 1, 7, and 14  shown that approximately 90 ± 0.9% , 89 ± 
2.9%, 90 ± 0.4% cells remained viable for pipette and 80 ± 3.9%, 80 ± 2.6%, 79 ± 
1.2% cells remained viable following BES (n-3) (Fig. 3.8 A and B). It was also 
shown that there was no significance between electrosprayed cells 80 ± 1.3% and 
non-BES mBMSC 90 ± 1.5 (Fig. 3.8 C). In addition, determining if cells were 
delivered in continuous distribution of even numbers during a spray period was also 
investigated. To demonstrate that mBMSC were not accumulating near the front or 
the back of the flow and BES at even rates into the collecting plate, we collected 
sequential fractions of cells as they emerged from the emitter. A suspension of 
mBMSC at 1 x10
6
cell/mL in cα-MEM medium was sprayed at a flow rate of 5ul/min 
and 100µL, at ~3-6kV. Three sequential fractions were collected in individual wells 
of a 24 well plate. Theoretically, if the flow of cells was continuous, 1.166 x 10
6
 
cells should be present in each fraction. It was found that over three separate 
experiments, fractions 1, 2 and 3 contained 90 ±0.04% , 87 ±0.1% and 90 ± 0.02%  
of the theoretical value (Fig. 3.9). This indicates that the cells were being delivered 
in even numbers during the spray period. 
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Fig 3.8 Viability of BES mBMSC. 1 x 10
6
 mBMSC/mL in cα-MEM were either 
pipette or BES into three wells of 24-well plate using flowrate of 5μL/min, 30 gauge 
single needle, 22mm PD and voltages ~3-6kV on three separate days (day 1, 7, 14). 
Viability of mBMSC for both pipette (A), and electrosprayed cells (B) were 
determined using 7-AAD staining assay and flow cytometry. It was shown that 
approximately 90 ± 0.9% , 89 ± 2.9%, 90 ± 0.4% cells remained viable for pipette 
and 80 ± 3.9%, 80 ± 2.6%, 79 ± 1.2% cells remained viable following BES. (C) 
Demonstrates an average viability for both pipette and electrosprayed cells while 
also indicating there were no significant difference between the non-BES cells 90 ± 
1.5% compare to the BES mBMSC 80 ± 1.3% (n=3).  
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Fig 3.9 Distribution of BES mBMSC. A suspension of mBMSC at 1 x10
6
cell/mL 
in cα-MEM medium was sprayed at a flow rate of 5ul/min and 100µL, at ~3-6kV. 
Three sequential fractions were collected in individual wells of a 24 well plate. 
Theoretically, if the flow of cells was continuous, 1.166 x 10
6
 cells should be present 
in each fraction. It was found that over three separate experiments, fractions 1, 2 and 
3 contained 90 ±0.04%, 87 ±0.1% and 90 ± 0.02% of the theoretical value. Analysis 
of sequential fractions demonstrated that cells were evenly distributed within the 
spray over the course of a 60 min spray (n=3). 
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3.8 Precision of spray emitted from the single needle configuration controlled 
the bio-electrospray mBMSC to target sites 
Controlling the BES of mBMSC is essential in TERM studies primarily to ensure 
cells reach their intended sites of interest. mBMSC were BES onto commercially 
available polyethylene fabricated scaffolds in a circular shape, to determine the 
accuracy of the spray emitted from the single needle configuration. The scaffolds 
were immediately stained with Methylene blue, wherein a blue/purple circle on the 
scaffolds demonstrated the presence of cells, and the lack of Methylene blue 
elsewhere on the scaffolds indicated the spray exclusively emitted towards its 
targeted site (Fig. 3.10 B). 
 
A similar study was carried out where mBMSC were BES to an intended area on the 
scaffold semi circular in shape. The scaffolds containing mBMSC were cultured in 
cα-MEM medium and Neutral Red stain. Although this is a vitality stain, it was used 
for observation purposes only in this study. A bright red semi-circle of BES 
mBMSC, in addition to a cluster of electrosprayed cells were observed on the 
scaffolds after 24hr (Fig. 3.11 B). In addition, brightfield images demonstrated 
similar results, while also showing no red staining in the surrounding areas at x4. 
This indicated that the spray emitting from the single needle configuration 
maintained a precision aim and BES mBMSC towards the target area (Fig. 3.11 D). 
Controls for both studies included mBMSC pipette onto scaffolds (Fig. 3.10 A and 
Fig. 3.11 A & C). 
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Fig 3.10 Accuracy of electrospray. Scaffolds were placed in transwell of 12-well 
plate and (A) Pipette mBMSC were dropped onto scaffold surface. (B) BES 
mBMSC were directed in a circular shape at ~3-6kV (depending on RH), flowrate of 
5μL/min, PD of 22mm and 30 gauge needle. Scaffolds were immediately stained 
with Methylene blue following electrospraying revealing blue/purple circle of cells. 
This demonstrated a precision spray emitted from the single needle configuration of 
Spraybase
®
.  
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Fig 3.11 In-depth study for electrospray accuracy. (A) Pipette mBMSC and (B) 
BES mBMSC directed in a semi-circle in addition to cells electrosprayed to specific 
site on commercially available scaffolds. Brightfield images for (C) pipette mBMSC 
and (D) BES mBMSC on scaffold at x4 magnification. All scaffolds were stained 
with Neutral Red. Accuracy of BES mBMSC to intended sites on scaffolds 
demonstrated the precise control of spray from the single needle configuration of the 
commercial electrospray apparatus. The lack of staining in the surrounding areas as 
shown by brightfield imaging confirms this result. Parameters included ~3-6kV 
(depending on RH), flowrate of 5μL/min, PD of 22mm and 30 gauge needle. 
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3.9 Discussion  
Vital electrospraying conditions such as jet stability and continuity are 
fundamentally affected by the apparatus set-up, liquid properties and external 
atmospheric conditions. Variations in in-house electrospray apparatuses and liquid 
solutions properties in different labs, directly impact on the parameters applied to 
achieve a stable, continuous Taylor cone. For the BES process, these parameters, in 
particular voltage, are critical to cell survival. Therefore, possessing a universal 
electrospray apparatus with a set of gold standard parameters has become a necessity 
for this cell delivery method.  Furthermore, due to ambiguity in electrospray 
experiments, reproducing data between labs have proven near impossible. Hence, 
this study addresses these problems by using a commercially available electrospray 
apparatus, Spraybase
®
, to create a set of universal parameters, while developing non-
toxic cell solutions with efficient properties for bio-electrospraying to occur. 
 
In establishing reproducible parameters, selecting compatible liquid solutions to BES 
cells which coincide with the single needle/ring-shape electrode configuration of 
Spraybase
®
, was a critical component. As previously discussed, it’s been widely 
reported that BES cells using a single needle causes an unstable Taylor cone with 
volatile sprays of cell solutions (Jayasingh et al., 2006 a&b; Odenwalder et al., 2007; 
Mongkoldhumrongkul et al., 2009). This is primarily due to issues with solution 
properties such as viscosity and electrical conductivity. Previous reports by Sahoo et 
al. (2010) and Ye et al. (2014) have described how high cell number with a 
minimum of 1x10
6
 cells/mL counteracted low viscosity levels, making it possible to 
BES cells. These studies also described using saline solutions such as PBS to negate 
difficulties with electrical conductivity.  
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However, a key component to the success of these studies included the use of a 
coaxial needle when BES the cells. Using Spraybase
®
 single needle configuration a 
stable, continuous Taylor cone was achieved, when high numbers of A549 cells were 
BES in common saline solutions, suggesting that the design of the commercial 
electrospray instrument supported this. In addition to Spraybase
®
 single needle 
configuration, its ring-shape electrode also contributed to a successful electrospray 
of viable A549 cells in PBS and PBS+0.5M EDTA (Fig. 3.3). To date, this is the 
first study reported to successfully BES cells in solution using a single needle, at low 
voltages, thus making it a break-through in electrospraying cells.  
 
Following this success, the next study was to prove that the parameters established 
herein regarding BES A549 were reproducible using a different cell type. 
Substituting the immortalised cell line A549 cells with primary mBMSC, cells were 
BES using identical parameters. Preliminary studies demonstrated that mBMSC 
electrosprayed at the exact same parameters. This indicated the commercial 
electrospray was capable of BES any cell type using the optimal parameters, 
suggesting reproducing data is achievable between experiments. However, further 
analyses demonstrated that mBMSC numbers had reduced significantly in 
comparison to initial studies with A549 cells following BES (Fig. 3.4). One possible 
explanation for this was due to the cell size. A549 cells are significantly smaller than 
mBMSC and it was hypothesised that mBMSC were too large to emit from the 30 
gauge single needle. However, having preformed similar studies described in Fig. 
3.2 and Table 4, it was quickly discovered that in addition to cell size, the number of 
cells involved and flowrate velocity, did not influence the quantity of viable 
mBMSC electrosprayed using this system.  
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Further studies revealed it was the saline solutions in which the cells were 
suspended, that proved detrimental to the BES high yields of viable mBMSCs. The 
cell solutions consisting of either PBS or PBS & 0.5M EDTA contained little to no 
nutrients for cell survival. The immortalised A549 cells are far more robust when 
surviving in unfavourable conditions compared to primary mBMSC cells. It was 
suggested that the lack of nutrients within the cell solutions may have account for 
limited cell viability, while cells were suspended in solution between experiments. 
Therefore, when mBMSC suspended in their own media (cα-MEM) were BES, a 
significant increase of sprayed cells was observed in the culture wells, after 24hrs 
(Fig. 3.5). These cells also retained vital MSC characteristics such as adhesion to 
plastic post electrospray, suggesting the low voltages were not having any immediate 
effect on the cells. This was confirmed by viability assays which determined that 
approximately 80% of mBMSC that were BES remained viable (Fig. 3.8).  
 
High ion charges from primary cells in addition with the culture medium, resulted in 
a highly conductive cell suspension (22.18mS/cm). Applying voltages to the highly 
electrically charged cell solution should have resulted in sparking and cell death. 
Interestingly however, it emerged to have a counter effect with positive results in 
relation to lowering amount of voltage applied for our experiments. It is suggested 
that the design of the Spraybase
®
 single needle/ring electrode configuration, in 
combination with mBMSC culture medium, which provided a balanced environment 
compatible with BES viable mBMSC, using reproducible parameters, at low 
voltages (~3-6kV).   
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As previously discussed achieving and maintaining a stable, continuous Taylor cone 
is essential to any electrospray experiment. Mongkoldhumrongkul et al. (2009) 
reported that they wanted to be the first to BES hTERT immortalized MSC at low 
voltages. However, they stated that jet stability and continuity was not a primary 
focus. Although they attempted to electrospray the cells at ~10kV using a coaxial 
needle, they eluded to the fact that jetting took place in an “unstable mode”. This 
prompted the group to investigate other jetting methodologies such as 
aerodynamically assisted bio-jets (AABJ) for cell delivery.  
 
Our studies demonstrated that the commercial electrospray apparatus at optimal 
parameters can generate two types of stable electrospray modes. This was depended 
on cell number within culture medium. mBMSC numbers were increased from 1x10
6
 
- 6x10
6
 cells/mL to initially determine if a specific cell number was relevant to 
establishing optimal parameters for the commercial electrospray. Spraybase
® 
visualization system demonstrated that the amount of cells did not affect the 
parameters applied, however, cell number significantly influenced the mode of 
electrospray generated. Sprays alternated between a plume and a jet mode when cells 
increased from 1x10
6
 cells/mL to 3x10
6
 cells/mL (Fig. 3.6 A & B). Unlike a coaxial 
needle where cells and liquid solutions are separate, the internal diameter of a single 
needle is required to accommodate both. By increasing the amount of cells in the 
solution possibly forced the cells into a central ligament, resulting in a jet mode 
emitting from the needle. Conversely, lower cell numbers in suspension indicated the 
solution was more liquid, allowing freedom for the spray to follow the shape of ring 
electrode. This type of spray covered more surface area of the well of collecting 
plate, which was also recorded by Odenwalder et al. (2009).  
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A continuity study indicated that BES mBMSC were evenly distributed into different 
culture wells, with high numbers spraying in solution for either mode (Fig. 3.9). 
 
Establishing the different types of spray modes was carried out between voltages of 
~3-6kV depending on the RH. In addition to cell numbers, determining if voltage 
contributed to spray mode variation was investigated when mBMSC were BES at 
10kV. Studies by Mongkoldhumrongkul et al. (2009), Sahoo et al. (2010) and Ye et 
al. (2014) all successfully BES stem cells at 10kV. However, once 10kV was applied 
to the solution of cells, the spray immediately became erratic and volatile, 
intermittently emitting the cell solution from the needle tip (Fig. 3.6 C). Sparking 
was observed on several occasions, immediately ending the experiment due to the 
danger to the user. The low numbers of mBMSC which successfully electrosprayed 
at this voltage, did not retain MSC morphology. In addition, cell debris was scattered 
throughout the culture well (Fig. 3.7). These results suggested that the high voltage 
induced cell death. Lowering the voltages to 7kV demonstrated similar results to 
studies carried out between ~3-6kV. When cell numbers were increased a BES of 
cells in jet mode was established. Similarly when cell numbers were decreased, a 
plume spray of BES mBMSC was observed, regardless of the voltage applied. 
 
Our final optimization study in the creation of a set of gold standard parameters to 
use with a commercial electrospray, for the sole purpose of reproducing data 
involved verifying accuracy of spray emitting from the needle. Directing an 
electrospray of cells towards an intended target site is crucial to delivery of cells 
when using jetting methodologies. 
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 In addition, Choi et al. (2008) and Ghasemi-Mobarakeh et al. (2008) described 
aligning stem cells onto scaffolds to grow in the direction of aligned fibres. This 
enhanced cell adhesion and proliferation for both skeletal muscle cell and nerve cells 
respectively. mBMSC were BES in circular shapes onto commercially bought 
scaffolds and stained with two different staining materials. The results demonstrated 
that the cells reached the intended target site indicating a precision electrospray was 
emitting from the single needle. In addition, the cell solution was controllable as the 
cells BES into circular shapes, as directed by the user. This demonstrated that this 
type of control and precision may prove advantageous in alignment studies, as cells 
can BES in even distribution along a contour. This assembly of cells is far more 
precise and intricate in comparison to seeding cells with a pipette in alignment along 
scaffold fibres (Fig. 3.10 and Fig. 3.11). The lack of staining elsewhere on the 
scaffolds further indicated that the BES mBMSC settled only at their intended areas.  
 
In summary, this study demonstrated that the commercially available electrospray 
apparatus can BES various cell types using specific parameters, generating a system 
for reproducing data between labs. Significantly this study demonstrated that a stable 
Taylor cone can be achieved using the single needle configuration at low voltages, a 
result thus far, which has not yet been reported. In addition, the BES of cells from 
the needle includes a continuous electrospray of high yields of viable cells, with 
mBMSC still maintaining vital MSC characteristics. These results indicated that the 
low voltages are not affecting the cells. The BES has displayed great precision in 
cells reaching intended target site while also demonstrating meticulous control over 
spray.  
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Furthermore, BES mBMSC in different circular shapes indicates that this system 
could be beneficial to new method in TE whereby cells maybe aligned along fibres 
which may prove beneficial to skeletal and nerve studies.  
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Chapter 4 
Optimisation of a commercial electrospinning 
apparatus and the establishment of optimal process 
and solution parameters to electrospin new polymer 
solutions involving: PEO, Collagen and Agarose 
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4.1 Introduction 
Electrospinning is a well documented technique that can generate fibrous structures 
of nano – to micrometre diameter. These fabricated constructs should mimic the 
structure and functions of natural ECM components (Chen et al. 2007; Chen et al. 
1998). Advances in electrospinning technologies for tissue engineering have been 
described previously in several reviews which discuss the importance of various 
criteria such as the electrospinning apparatus, voltage parameters, polymers, surface 
areas, fibre and pore sizes, scaffold morphology, cell types and growth factors, when 
electrospinning fibres (Rim et al. (2013); Tamayol et al. (2013); Shin et al. (2012); 
(Agarwal et al. (2008); (Huang et al. (2003)).  
 
As previously discussed (chapter 1), modern electrospinning instruments are 
manufactured based on a design by Baumgarten (1971). The fundamental principles 
include using a power supply to induce high voltage in order to charge a polymer 
solution, contained in a syringe.  Since this is an inexpensive method for scaffold 
fabrication, most systems are in-house set-ups. Consequently, optimal conditions for 
electrospinning vary between the different polymer/solvent systems, wherein each 
system parameters must be optimised through a time consuming process. 
Furthermore, this adversely affects the ability to reproduce results between 
experiments, as there are no set of standardised parameters for electrospinning fibres. 
 
In addition to the apparatus, particular consideration must be given to the types of 
polymers used when electrospinning fibres. Physical and chemical properties of 
polymers directly influence whether electrospinning can be achieved.  
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These properties determine the outcome of scaffold surface topography and fibre 
morphology, in addition to fibre and pore size.  
 
Both organic and synthetic polymers have been used in the development of artificial 
3D constructs. Although hydrophilic organic polymers such as chitosan, collagen, 
gelatin and fibrin provide cell adhesion and vital cellular signals, they have poor 
mechanical properties and are relatively weak. In contrast, hydrophobic synthetic 
polymers, such as polylactic acid (PLA), polyglycolic acid (PGA), and their 
copolymers including FDA-approved poly(lactic-co-glycolic acid) (PLGA), provide 
easy control of microstructure, strength and degradation rate. However, these 
polymers lack growth factors and other signals to direct cell growth, proliferation 
and differentiation. There is no universal solvent for both hydrophilic natural 
polymer and hydrophobic synthetic polymers so the polymers cannot simply be 
blended together. Therefore, a range of new techniques are being developed for the 
generation of hybrid scaffolds. 
 
The primary aim of this study was to address the problems associated with (1) the 
time consuming process of establishing parameters for in-house built electrospinning 
apparatuses, (2) electrospinning hybrid polymers and (3) issues associated with 
experimental replication. These obstacles were addressed by modifying the 
commercial electrospray apparatus to electrospin common polymers such as 
poly(ethylene oxide) (PEO) and polyethylene glycol (PEG), generating a set of 
standardised parameters for these polymers and system. PEO and PEG were blended 
either together, and/or with organic polymers to create novel hybrid polymer blends. 
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The resultant electrospun fibres were examined in relation to scaffold surface 
texture, fibre morphology, and fibre and pore sizes. 
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4.2 Modified electrospray apparatus capable of electrospinning fibres  
Several studies have accredited the success of their functioning, 3D fabricated 
constructs, to the design of their in-house built electrospinning systems. Li et al. 
(2013) developed a novel method whereby they combined micropatterning using a 
femtosecond laser, with electrospinning. This technique allowed for the fabrication 
of porous structures with microchannels that can direct hMSC cellular responses. 
Whereas Wang et al. (2009) developed a technique for rapid fabrication (<3 h) of 
scaffolds by simultaneously electrospinning elastase-sensitive polyurethaneurea 
(PUTU) nanofibres while electrospraying and encapsulating growth factor IGF-1 
into poly (lactide-co-glycolide) (PLGA) microspheres. During the 
electrospinning/electrospraying process, these nanofibres were assembled into 
scaffolds. Although these studies have shown some success in addressing issues 
associated with artificial constructs, their systems are highly complex. For other 
groups to attempt and replicate these systems may prove near impossible. We 
propose that the commercially available Spraybase
®
 instrument could be used to 
standardise instrumentation between experiments. We therefore examined if and how 
Spraybase
®
 could be used to electrospin fibres.  
 
Ground electrode shape was modified from ring-shape into a rectangular-shape. 
Electrode lengths measuring from 100mm – 500mm were investigated to electrospin 
fibre meshes. It was found that the ground electrode approx 300mm provided the 
adequate length to encourage fibres to attach to the sides of the electrode (Fig. 4.1 
A). This allowed for a build up of thin layers, ultimately resulting in a fibrous mesh 
(Fig 4.1 B).  
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Several process parameters were adjusted including voltage, needle gauge, flowrate 
and PD to electrospin PEO/PEG/agarose, PEO/collagen/cα-MEM culture medium 
and PEO/agarose/cα-MEM culture medium, fibres using this device. Table 5 
demonstrated the conditions favourable with successful electrospinning of fibres and 
are highlighted in red. Those shown in black indicate the parameters examined but 
cannot fabricate fibres using this device. It was found that temperatures above 32°C 
and RH over 50% significantly influenced electrospinning from occurring. 
Therefore, those highlighted in red where further analysed to determine optimal 
parameters to electrospin fibres with either/or PEO and PEG included in the polymer 
blends. Optimal electrospinning parameters for this instrument include, 3μL 
flowrate, with voltages varying between ~7-9kV, using single needle configuration 
with 23 gauge conducting needle at a potential difference of 24mm. 
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Fig. 4.1 Configuration of electrospinning set-up. (A) Rectangular-shape ground 
electrode measuring approx 300mm to support mesh fabrication. (B) Optimal 
parameters for electrospinning fibres using ‘Generation 1’ BES instrument supplied 
by AVECTAS. Flowrate 3μL, voltage ~7-9 kV, 23 gauge conducting needle, with 
potential difference of 24mm. Photographs taken at various stages of the 
electrospinning process.   
 
 
 
 
 
 
 
A 
B 
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Table 5: Summary of parameters wherein polymer blends involving PEO and/or 
PEG electrospun fibres (red) and parameters examined but unsuccessful in 
electrospinning fibres (black) using single needle configuration and ring-shape 
electrode.  
 
 
Flow Rate 
(μL/min) 
 
Voltage 
(kV) 
 
Single 
Needle 
(Gauge) 
 
Potential 
Difference 
(mm) 
Temperature 
(°C) 
Relative 
Humidity 
(%) 
1 3.50 23 17 15.6 29.4 
2 3.55 27 19 17.5 30.5 
3 4.00 30 20 18.5 36.7 
4 4.55 32 22 19.4 39.2 
5 5.55  23 20.0 41.3 
6 6.00  24 20.1 45.2 
 6.55  25 20.6 46.3 
 7.50  26 22.5 46.9 
 7.55  27 23.8 48.0 
 7.90   25.3 51.4 
 8.50   28.0 55.6 
 8.80   29.5 56.6 
 9.3   30.0 58.0 
    31.3 60.3 
    31.5  
    32.6  
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4.3 Generation of novel organic and synthetic polymer blends for 
electrospinning process with commercial electrospray 
Initial electrospinning studies involved using both PEO and PEG. Although these 
polymers have critical features required for electrospinning purposes such as high 
viscosity levels and strong elasticity capabilities, it is widely reported that these 
solutions will dissolve easily at room temperature. Having attempted and failed to 
electrospin numerous concentrations of these two polymers, agarose, 
a polysaccharide polymer generally extracted from seaweed, was introduced to the 
polymer blend. Bonino et al. (2011) had previously described using alginate which is 
also a natural polysaccharide extracted from seaweed, to successfully electrospin 
alginate-based nanofibres in combination with PEO.  Agarose has similar properties 
to alginate thus the reason for its selection to this polymer blend. In addition to 
providing increased viscosity to polymer mix for electrospinning to occur, agarose 
also acted as a strengthening agent for the scaffolds.  
 
PEO/PEG/agarose scaffolds were electrospun using Spraybase
® 
and optimal 
processing parameters, at varying agarose concentrations (Table 6).  Ambient 
parameters particularly RH, significantly influenced agarose polymer concentrations 
present in the mixture, while also impacting on whether electrospinning of these 
scaffolds transpired. Increasing RH from 30 – 40% resulted in increased agarose 
polymer concentrations (w/v), while electrospinning ceased functioning completely, 
when RH rose above 40%. Some success was achieved with this polymer 
combination, but the resulting mesh proved extremely fragile. No analyses were 
performed on this fibrous construct as it dissolved at room temperature almost 
immediately post spinning. 
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Table 6: Summary of PEO/PEG/Agarose solutions electrospun at various 
concentrations using optimal parameters of flowrate 3μL/min, voltage ~7-9kV. 23 
gauge single needle and PD 24mm.  
                                                                                                                                                                                    
PEO/PEG/Agarose 
30%w/v/50%w/v/25%w/v 
PEO/PEG/Agarose 
30%w/v/50%w/v/50%w/v 
PEO/PEG/Agarose 
30%w/v/50%w/v/100%w/v 
Ratio: 
PEO/PEG/Agarose 
Spun 
Fibre 
Y/N 
Ratio: 
PEO/PEG/Agarose 
Spun 
Fibre 
Y/N 
Ratio: 
PEO/PEG/Agarose 
Spun 
Fibre 
Y/N 
1: 0.1 :0.9 N 1: 0.1 :0.9 N 1: 0.1 :0.9 N 
1: 0.2 :0.8 N 1: 0.2 :0.8 N 1: 0.2 :0.8 N 
1: 0.3 :0.7 N 1: 0.3 :0.7 N 1: 0.3 :0.7 N 
1: 0.4 :0.6 N 1: 0.4 :0.6 N 1: 0.4 :0.6 Y 
1: 0.5 :0.5 N 1: 0.5 :0.5 Y 1: 0.5 :0.5 Y 
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4.4 Collagen versus Agarose as a primary polymer in fabrication of novel 
electrospun scaffolds 
The fundamental objective when fabricating fibres is to mimic the natural ECM, 
ultimately encouraging cell adhesion and survival in vivo. Collagen is a major 
insoluble fibrous protein in natural ECM and connective tissue, making it a preferred 
material when fabricating artificial 3D constructs as seen in studies by Prabhakaran 
et al. (2009), Chan et al. (2009) and Kazemnejad et al. (2009). Therefore, 
commercially sourced 3D collagen I Rat Tail was combined with PEO and MSC cα-
MEM culture medium, to create a novel polymer mix. PEO was selected due to its 
superior viscosity properties, compared to PEG, while the presence of cα-MEM 
culture medium was to provide nutrients to cells. Additionally, results from 
electrospinning PEO/PEG/agarose fibres although week, proved promising, 
prompting further investigations into the use of agarose in electrospinning. Thus, a 
second polymer mix was created, combining agarose with PEO and cα-MEM culture 
medium.  
 
Numerous concentrations of PEO, collagen, cα-MEM culture medium and agarose 
were examined in order to electrospin PEO/collagen/cα-MEM, and PEO/agarose/cα-
MEM fibres, using Spraybase
®
 commercial electrospray. Final optimal 
concentrations for commercially bought 3-D collagen and PEO were 2% and 30% 
w/v respectively. However increasing agarose polymer to a final concentration of 
150% w/v, provided the best viscosity levels essential for fabrication of 
PEO/agarose/cα-MEM scaffolds. It was also recorded that by increasing the ratio of 
PEO to collagen or agarose, and culture medium x6 (6:1:1), both polymer blends 
electrospun fibres at flowrate 3μL/min and PD of 24mm.  
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Voltage was inconsistent for collagen based scaffolds and fluctuated constantly 
between ~6-9 kV, within the same experiment. In contrast, agarose based scaffolds 
electrospun repetitively between 6-7 kV regardless of the experiment.  
 
Environmental parameters such as temperature and RH impacted on scaffold 
fabrication for both polymer mixtures.  It was near impossible to electrospin fibres 
above 32°C or with RH of 50%. However, once parameters reached optimal 
conditions, solid PEO/collagen/cα-MEM and PEO/agarose/cα-MEM scaffolds were 
fabricated, and their surface texture, pore and fibre sizes investigated. 
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4.5 Contrasting surface topography for collagen and agarose based scaffolds 
Surface topography refers to the surface texture of a scaffold. It is generally 
characterised by a predominant surface pattern and its surface roughness. This 
“roughness” is a measure of the finely spaced surface irregularities (Degarmo et al., 
2003). Functional 3D scaffolds can electrospin fibres in various patterns including 
“random pattern” or “aligned patterns”. These contribute in providing the scaffolds 
with strong, smooth, flat surface textures, in order to accommodate cell viability and 
cellular responses such as adherence, proliferation and differentiation.  
 
4.5.1 Surface topography for electrospun PEO/collagen/cα-MEM scaffold  
The surface texture for electrospun PEO/collagen/cα-MEM scaffolds was initially 
examined visually, by eye. The surface was found to be a rough mesh, with apertures 
sporadically located within the scaffold (Fig. 4.2 A). Brightfield microscopy 
confirmed these observations with perforations visible throughout the scaffold (Fig. 
4.2 B). It was also apparent that several layers of fibres electrospun at some areas on 
the rectangular-ground electrode, while minimum layering was formed at others 
(Fig. 4.2 C). Further investigations using scanning electron microscope (SEM) 
revealed the extent of irregularities in the surface texture for these scaffolds.  
Although fibres were electrospun in a random pattern, the amount of inconsistencies 
in the fibrous layers covering the electrode demonstrated the random pattern was not 
intentional, but more accidental as to wherever the fibres settled (Fig. 4.3 A & B). 
Furthermore, SEM demonstrated inconsistencies in fibre morphology. In addition to 
fibre thickness, random bead shape globules were also present (Fig. 4.3 C). Gaps and 
tears were observed throughout the construct indicating fabrication of a week 
scaffold. 
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Fig 4.2 Surface texture for PEO/collagen/cα-MEM scaffold at ratio 6:1:1. (A) 
Photograph exposing rough surface texture (black box) with perforations (red box) 
throughout scaffold. (B) Brightfield image of holes within scaffold at x4. (C) 
Brightfield imaging of fibrous mesh layers electrospun at one position, while 
disregarding other areas at x4. Optimal parameters used involved flowrate 3μL/min, 
voltage ~7-9kV. 23 gauge single needle and PD 24mm. 
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Fig 4.3 SEM of surface texture for PEO/collagen/cα-MEM scaffolds at ratio of 
6:1:1. (A) Limited electrospun fibrous layer with inconsistent fibre morphologies. 
(B) Abundant fibrous layers in random pattern settled at a specific scaffold location 
on ground electrode. (C) Bead formation on scaffold. Optimal parameters used 
involved flowrate 3μL/min, voltage ~7-9kV. 23 gauge single needle and PD 24mm. 
 
 
A 
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4.5.2 Surface topography for electrospun PEO/agarose/cα-MEM scaffold 
In contrast to the collagen based scaffold, surface texture for PEO/agarose/cα-MEM 
scaffold revealed a smooth, even surface, with no obvious perforations (Fig. 4.4 A). 
Brightfield microscopy confirmed these findings with images showing flat, uniform 
scaffold surface featuring consistent layers of PEO/agarose/cα-MEM fibres at x10 
(Fig.4.4 B). When compared to a commercially available pre-fabricated polyethylene 
scaffold using brightfield imaging, results demonstrated that both scaffolds appear to 
have the similar surface textures. This indicated that the agarose scaffolds were more 
cohesive than the collagen-based scaffolds, suggesting that the former agarose 
electrospun fibres have similarities with apparent conventional fibre properties, when 
using the commercial apparatus (Fig. 4.4 B & C). 
 
SEM imaging further demonstrated random pattern fibres were electrospun, creating 
a stable mesh, covering all areas of the construct. Fibre morphology appeared 
homogeneous with little to no bead formation (Fig 4.5). 
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Fig 4.4 Surface texture for PEO/agarose/cα-MEM scaffolds at ratio 6:1:1. (A) 
Photograph of smooth, even surface texture with no obvious perforations. (B) 
Brightfield image of PEO/agarose/cα-MEM scaffold surface texture including pores 
at x10. (C) Commercially available pre-fabricated polyethylene scaffolds at 
magnification x10. PEO/agarose/cα-MEM scaffold demonstrate similar surface 
texture to commercially bought polyethylene scaffolds. Optimal parameters used for 
electrospinning fibres involved flowrate 3μL/min, voltage ~7-9kV. 23 gauge single 
needle and PD 24mm. 
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Fig 4.5 SEM of surface texture for PEO/agarose/cα-MEM scaffolds at ratio 
6:1:1. Fibres electrospun in a random pattern. Fibres are uniform and appear to 
assemble in consistent layers. This is seen for all PEO/agarose/cα-MEM scaffolds. 
Fibres electrospun using optimal parameters of flowrate 3μL/min, voltage ~7-9kV. 
23 gauge single needle and PD 24mm. 
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4.6 Extensive pore size variation in collagen scaffolds contrasted with 
homogenous pore sizes for agarose scaffolds 
An inherent limitation to using electrospun scaffolds in TE applications is small pore 
size. This has proven to be a major problem as mammalian cells varies in size 
making infiltration for large cells, such as MSC, through scaffolds almost 
impossible. Migration of cells through a biodegradable scaffold is crucial for 
successful transplant and healing of a synthetic graft onto a defect. Additionally, 
small pore sizes restrict nutrient delivery and the removal of biomaterial waste. 
 
SEM analyses indicated that electrospun PEO/collagen/cα-MEM scaffolds 
comprised of various pore sizes throughout the scaffold. Smallest pore size recorded 
was 10.1μm, with the largest pore size measuring at 75.1μm (Fig.4.6). In 
comparison, electrospun PEO/agarose/cα-MEM demonstrated uniform pore sizes 
ranging from 5.97μm – 6.38μm (Fig. 4.7). These results were consistent for several 
electrospun collagen and agarose scaffold.  
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Fig 4.6 SEM of pore sizes for PEO/collagen/cα-MEM scaffolds at ratio 6:1:1. 
(A) Smallest pore size recorded. (B) Largest pore size recorded. Fibres electrospun 
using optimal parameters of flowrate 3μL/min, voltage ~7-9kV. 23 gauge single 
needle and PD 24mm. 
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Fig 4.7 SEM of pore sizes for PEO/agarose/cα-MEM scaffolds at ratio 6:1:1. (A) 
Smallest pore size recorded. (B) Largest pore size recorded. Pore sizes appear 
consistent. Fibres electrospun using optimal parameters of flowrate 3μL/min, voltage 
~7-9kV. 23 gauge single needle and PD 24mm. 
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4.7 Electrospun PEO/collagen/cα-MEM fibre diameters varied in thickness 
compared to uniform PEO/agarose/cα-MEM fibres  
Electrospun fibres provide scaffolds with critical similarities to natural ECM. 
Establishing an ideal fibre size is vital when electrospinning fibres as they can 
provide excellent interconnectivity and control porosity of scaffolds (Pham et al., 
2006).  Scaffold fibres can range from nano - micro scale. However nanofibres are 
preferred, as they have been cited on numerous occasions to closely mimic natural 
properties of the ECM (Rim et al., 2013; Ladd et al., 2011; Pham et al., 2006). 
 
Fibre diameters for both collagen and agarose type scaffolds were investigated. SEM 
analyses indicated electrospun fibre diameters for PEO/collagen/cα-MEM ranged 
from 795nm - 3.18μm (Fig 4.8).  In addition SEM imagining also demonstrated fibre 
diameters for PEO/agarose/cα-MEM scaffolds measured between 1.57μm – 1.58μm 
(Fig. 4.9). Although fibre thickness remained uniform amongst agarose scaffolds, 
fibre diameters remained at micro level. Mean results consistent with several 
constructs fabricated using these polymer mixtures. 
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Fig 4.8 SEM of fibre diameters for PEO/collagen/cα-MEM scaffolds at ratio 
6:1:1. (A) Thinnest fibre diameter recorded for these scaffolds. (B) Thickest fibre 
diameter evident for these scaffolds. Wide variation in fibre diameters was observed 
using SEM for electrospun scaffolds using optimal parameters of flowrate 3μL/min, 
voltage ~7-9kV. 23 gauge single needle and PD 24mm. 
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Fig 4.9 SEM of fibre sizes for PEO/agarose/cα-MEM scaffolds at ratio 6:1:1. (A) 
Thinnest fibre diameter recorded. (B) Thickest fibre diameter measured. Based on 
several fabricated constructs fibre size appear uniform in diameter, yet remain at the 
micro level. Fibres electrospun using optimal parameters of flowrate 3μL/min, 
voltage ~7-9kV. 23 gauge single needle and PD 24mm. 
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4.8 Discussion 
Significant advances have been made in the development of biomaterials for TE 
applications, however there is still a pressing need for viable clinical alternatives to 
current the gold standard treatment of autografting and allografting. Electrospinning 
nanofibres have become extremely prominent in TE field over the last two decades. 
In addition to being a relative simple and cheap process, features such as scalability, 
adaptability, and capacity to form fibres on both the nano and micro scale, make it 
most favourable method for scaffold fabrication (Sill & von Recum, 2008).  
 
A significant problem with the electrospinning process is the ability to employ a 
single system for scaffold fabrication. As it’s relatively simple and cheap to build an 
electrospinning apparatus, almost every study describes using an in-house device 
when electrospinning fibres. However, current studies also reported enhancing their 
in-house electrospinning set-up by combining it with more complicated devices, to 
fabricate a more effective 3D construct. Therefore, the possibilities replicating these 
studies are virtually impossible. Li et al (2013) combined femtosecond lasers with 
electrospinning. Stankus et al., (2007) developed a dual 
electrospraying/electrospinning apparatus where simultaneous electrospraying of 
cells and electrospinning of nanofibres occurred. Techniques such as microcontact 
printing and photolithography have also been employed in combination with 
electrospinning, to develop scaffolds with more advanced multiscale structures (Li 
and Xia, 2004, Liang et al. 2007). Although these complex systems have discovered 
new ways to address various issues associated with scaffolds including fibre and 
pore size, fundamentally, they negatively impact on the ability to replicate similar 
scaffolds between different labs.  
133 
 
As the aforementioned apparatuses design cannot simply be reproduced, it renders 
the groups optimal parameters established per apparatus obsolete. Furthermore, the 
time taken to establish the optimal parameters per instrument can be a lengthily 
process, prolonging the investigations into more significant experiments including 
the scaffold application in TE. 
 
In addition to the electrospinning apparatus, the biomaterials selected are crucial to 
scaffold fabrication. Over 150 known polymers have been electrospun with the 
expectation to advance cellular transplantation in TERM. However, difficulties in 
developing scaffolds with adequate fibre thickness for cell adhesion, pore sizes for 
increased cell infiltration through scaffold, and appropriate GF and nutrients to 
induce cell differentiation, still remain. Polymers are usually selected based on their 
mechanical and physical properties for electrospinning purposes, their capacity to 
provide a cellular microenvironment that closely mimics the natural ECM, and their 
ability to degrade. Typically, synthetic polymers are selected based on FDA 
approval, implying these polymers are compatible with in vivo applications.  
 
In an effort to challenge these issues, the primary focus in this study was to establish 
a universal system with optimal parameters for scaffold replication between labs. By 
simply modifying the ground electrode shape for the commercially available 
apparatus Spraybase
®
, this provided the components to establish reproducible 
optimal parameters to electrospin commonly used polymers such as PEO and 
collagen (Fig. 4.1). Fibres electrospun from these polymers provided a benchmark 
for voltage, PD, flowrate, needle gauge and even polymer concentration for the 
commercial system.  
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Furthermore, supplying a commercially available apparatus with optimal parameters 
can eliminate the immense timescale required, when optimising in-house apparatus. 
Therefore, this allows additional time to focus on the generation of new biomaterials, 
which can electrospin fibres closely mimicking the natural ECM.  
 
In addition to process parameters (voltage, flowrates, PD etc.), this study’s 
preliminary investigations demonstrated the importance of solution parameters to the 
electrospinning process. As described in chapter 1, the solution parameters include 
polymer concentration, solution conductivity and solution viscosity. Due to the high 
volume of successful studies wherein PEO and PEG electrospun fibres were utilised, 
our initial investigations involved using these soluble solvents to electrospin fibres. 
However, regardless of the ratio of polymer mixture for either solvent, the solution 
regularly lacked the ability to electrospin fibres, using the commercial device. 
Moreover, the ability to electrospin this polymer mixture with the apparatus proved 
inconsistent such that, every electrospinning experiment involving this polymer 
blend used different process parameters, frequently ending with failed attempts in 
producing fibres. A possible reason for this maybe due to issues with low viscous 
levels of the solution. In order to electrospin fibres with the commercial electrospray, 
the ratio of polymer mixture used often had a liquid appearance to the solution. This 
generally indicated the solution had low viscosity levels, whereas the collagen and 
agarose mixtures usually had a honey-type consistency to the solution. Therefore the 
ability to electrospin fibres when using the commercial apparatus and the PEO/PEG 
mixtures, were practically impossible. The addition of agarose to this mix increased 
the viscosity levels such that agarose concentrations of 50%w/v and 100%w/v in 
water electrospun fibres.  
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However, the fabricated PEO/PEG/agarose scaffolds remained extremely fragile and 
dissolved almost immediately post electrospinning at room temperature. Therefore 
new polymer mixtures incorporating PEO and/or collagen were designed, and their 
electrospinning capabilities were examined. 
 
PEO and collagen are polymers commonly used in the electrospinning process. PEO 
has excellent high viscosity and strong elasticity properties, whereas collagen is a 
primary structural protein in the ECM in various connective tissues in animals. In 
addition to essential electrospinning properties, PEO has been used for various 
studies due to its ability to dissolve in water. Baker et al. (2008) and Phipps et al. 
(2012) overcame issues with small pore sizes by using PEO as a “sacrificial 
component” in their electrospun scaffolds. This involved co-electrospinning PEO 
fibres with the main scaffold component, dissolving the PEO from the scaffold by 
submerging it in water after fabrication, inevitably leaving behind larger pores within 
main scaffold.  
 
Collagen has been reported in numerous studies as a key component in providing 
cell adhesion and/or inducing cell differentiation to electrospun scaffolds. Chan et al. 
(2009) demonstrated more than 45% hMSC adhered to electrospun pure collagen 
nanofibres after 30 min at room temperature. Prabhakaran et al. (2009) made the first 
report of MSC differentiation on 3D poly(L-lactic acid)-co-poly-(ε-
caprolactone)/Collagen (PLCL/Col) nanofibrous scaffolds. Whereas  Kazemnejad et 
al. (2009)  fabricated a variety of 3D scaffolds and examined their ability to induce 
hBMSC to differentiate into functional hepatocytes.  
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Electrospun poly(ε-caprolactone), collagen and polyethersulfone 
(PCL/collagen/PES) nanofibres were found to be the most successful and the 
investigators speculated that the addition of collagen to PCL/PES nanofibres was the 
critical factor. These studies therefore prompted the polymer mixture of PEO with 
collagen. The introduction of cα-MEM culture medium to the mixture was suggested 
due to it being the culture medium for MSC, therefore providing nutrients to cells. 
PEO/collagen/cα-MEM scaffolds were successfully electrospun using the 
commercial electrospinning apparatus. The optimal established process and solution 
parameters provided a benchmark for future electrospinning using this apparatus 
with PEO and/or collagen. Furthermore, having previously established some success 
with the addition of agarose to PEO and PEG polymer blends, and the reported 
success of Bonino et al. (2011) using a combination of PEO and alginates, a further 
polymer mixture was developed combining PEO, agarose and cα-MEM. Surface 
texture, fibre morphology and pore and fibre sizes were investigated for 
PEO/collagen/cα-MEM and PEO/agarose/cα-MEM scaffolds. 
 
Several studies describe the surface texture of the fibres as the critical component in 
maximising the adhesive properties of scaffolds. Both Li et al. (2013) and 
Gustafsson et al. (2012)  reported similar findings when they investigated in vitro 
biocompatibility of  their synthetic 3D PCL nanofibre scaffolds and electrospun 
polyethylene terephthalate (PET) and polyurethane (PU) scaffolds respectively. 
Their results found that coating the scaffolds with adhesion proteins yielded no 
increase in cell density or proliferation compared to non-coated scaffolds. This 
suggested it was scaffold surface texture that was vital to their cell/scaffold 
interactions.  
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The fabricated collagen scaffolds demonstrated a rough, perforated surface texture, 
with uneven fibre distribution throughout the scaffold (Fig. 4.2). In contrast, the 
agarose scaffolds demonstrated a smooth and refined surface texture, with no 
perforations present. The fibres for the agarose scaffolds also aligned in a random 
pattern developing a symmetrical layered mesh, indicating these may provide a 
surface area acceptable to cell adhesion (Fig. 4.4).  
 
A possible reason for the contrast in the surface textures for the collagen and agarose 
scaffolds maybe due to viscosity levels for PEO/collagen/cα-MEM solution. 
Regardless of how little collagen was added to the blend, its presence caused the 
solution to remain quiet liquid. Therefore, PEO was increased to counteract the 
liquidity generating a more viscous blend of polymers. Although the polymer 
solution was viscous enough to electrospin fibres using the commercial electrospray, 
the mixture appeared more liquid than glutinous when compared to the agarose 
mixture. In addition, temperature has been shown to change the viscosity of the 
polymer jet (Pham et al., 2006). It was recorded on several occasions how 
temperature dictated whether electrospinning of the collagen scaffolds transpired. 
Optimal temperatures for electrospinning these scaffold varied between 18-25°C, in 
comparison to the agarose scaffolds which could electrospin up to 32°C. It is 
possible temperature had a negative impact on the already low viscous collagen 
solution, generating a fragile fibre, with a rough and perforated surface texture.  
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SEM for collagen scaffolds demonstrated the presence of bead formation on its 
electrospun fibres using the commercial apparatus (Fig. 4.3).  Deitzel et al. (2001) 
reported that by increasing the voltage when using PEO in water solution causes the 
Taylor cone to subside, which enhances beading of fibres. This is one possible 
reason as to why beading was observed on PEO/collagen/cα-MEM scaffolds. 
Although voltage fluctuated within experiments, it was generally in the direction 
from low to high, i.e. increasing from 6-9kV. Voltage remained between ~6-7kV for 
agarose-based studies, with SEM indicating no obvious beading on the fibres of 
these scaffolds (Fig. 4.5). In addition to increasing voltage, high humidity may have 
also impacted on the collagen fibres morphology. Pham et al., (2006) described how 
excessive humidity may prevent solvent evaporation during the electrospinning 
process, resulting in bead formation on the fibres. RH for these experiments ranged 
between 30-48%. Although RH did not seem to affect the electrospinning of 
PEO/agarose/cα-MEM scaffolds, it may have contributed to bead formation within 
collagen scaffolds, in combination with increased voltages.  
 
Optimally designed pore sizes provide structural space for cell migration and enable 
the exchange of nutrients between the scaffold and environment, while eliminating 
waste. Small pore sizes have proven problematic to these processes, and are recorded 
to range between ~10–15 μm (Leong et al., 2010; Shabani et al., 2012). Regarding 
the current study the electrospun collagen scaffolds fabricated pore sizes ranged 
from 10.1 - 75.1μm, whereas the agarose scaffolds electrospun pores measuring as 
little as 5.97 - 6.38μm (Fig. 4.6 and Fig. 4.7). Although PEO/collagen/cα-MEM 
polymer blends electrospun pores ranging from small to medium sizes, pores were 
constantly inconsistent in size for each fabricated collagen construct.  
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Whereas PEO/agarose/cα-MEM polymer mixture electrospun scaffolds with uniform 
pores, however, these were miniature in size, thus rendering them ineffective to any 
possible future cellular activity.  
 
In an attempt to address the issues with pore size inconsistencies for collagen 
scaffolds and extremely small pore sizes for agarose scaffolds, both were placed in 
water with the intention to dissolve PEO, making it a “sacrificial component” as 
described by Baker et al. (2008) and Phipps et al. (2012). However, both scaffolds 
fully dissolved once submerged in water. This raised questions to both scaffolds 
strength and their ability for hosting cells while also culturing them in medium, for 
future experiments.  
 
It has been well documented that polymer concentration greatly influences fibre 
formation. Dissolving sufficient amount of polymer in a solvent is critical to fibre 
structure, as polymer strands must overlap in order to physically link and form fibres 
(Sill & von Recum, 2008). Controlling fibre thickness is a prominent issue when 
electrospinning polymers. Gupta et al. (2005) and Chen et al. (2008) demonstrated 
that increased polymer concentration correlated with increased fibre thickness. For 
the electrospun collagen scaffolds SEM demonstrated that the fibre diameters 
measured between 759nm - 3.18μm, whereas agarose fibres electrospun between 
1.57 - 1.58μm (Fig. 4.8 and Fig. 4.9). Controlling fibre thickness for collagen 
scaffolds proved difficult. Increasing the collagen polymer concentration resulted in 
a liquefied polymer mix, incapable of electrospinning fibres using the commercial 
device.  
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Whereas increased PEO polymer concentrations resulted in a high viscous solution 
which blocked the conducting needle tip, preventing the electrospinning process 
from occurring. Final ratio of PEO:collagen:cα-MEM, provided the correct polymer 
mixture to electrospin fibres using commercial apparatus. However, fibre diameters 
remained inconsistent for this mixture resulting in the electrospinning of both 
nanofibres and microfibers. Agarose-based polymer blends electrospun uniform 
fibres, with diameters on the micrometre scale. However, various studies reported 
that nanofibrous scaffolds had closer behaviours to natural ECM than microfibres. 
The nanofibres provided a more functional connective microenvironment for cell 
adhesion and differentiation, when compared to those on the microfibril scaffolds. 
Nonetheless, Li et al. (2013) demonstrated that microfibres can permit successful 
cellular and nutrient infiltration with fibre and pore sizes as little as of 0.6μm and 
1.2μm respectively. However, in comparison to our agarose-based scaffolds, their 
specially designed laser/electrospun hybrid matts were extremely durable. Agarose 
scaffolds although strong enough to remain functional at room temperature, 
dissolved once cells were seeded onto them, and submerged in media.  
 
As a result, it is proposed that these scaffolds may contribute to new system such 
that, both nanofibres and microfibers are incorporated within the same scaffold. 
Study by Ju et al. (2010) described how combining both nano and microfibers 
allowed for better integration of smooth muscle cells (SMC), and development of 
multiple SMC layers when examining the potential to create vascular grafts. Luminal 
epithelial cell (EC) monolayer was supported when PCL/collagen nanofibres were 
electrospun with fibres approximately 270 nm in diameter.  
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Surrounding this layer, PCL/collagen fibres with diameters of approximately 1μm, 
2.4μm and 4.45μm in different groups were added in order to increase the pore size. 
Scaffolds were found to support EC on the luminal nanofiber layer and SMC growth 
on the outer microfiber layer. SMC infiltration significantly increased when 2.4 μm 
and 4.45 μm fibres were used, as these fibre sizes provide pore sizes large enough 
for cells to grow into. This is not a feature generally observed with pure nanofibers. 
 
In summary the primary investigation for this study was to establish a universal 
apparatus with standardised, optimal parameters to electrospin fibres. Simple 
modifications to ground electrode from the commercial electrospray apparatus, 
provided the components required for electrospinning to occur. Specific process and 
solution parameters such as voltage, polymer concentration, solution viscosity, 
temperature and humidity directly influenced the electrospinning of both collagen 
and agarose type scaffolds, when using the commercial electrospinning apparatus. 
Although both constructs had similar electrospinning parameters applied, the final 
fabricated scaffold was in complete contrast to each other. Collagen scaffolds proved 
fragile with perforations throughout the construct. Its uneven, rough surface texture 
was fabricated from fibres of varying thickness, measuring from nano to micro 
metres. This adversely impacted on pore size electrospinning both small and medium 
sized pores for these scaffolds. In addition, fibre morphology showed obvious bead 
formation on the fibres.  
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In contrast, agarose scaffolds proved more robust with smooth, even surface textures. 
Fibre diameters and pore sizes appeared uniform and consistent within these 
scaffolds. However pore size measured below par for any possible cellular activity to 
take place on these constructs. However, agarose electrospun fibres may hold some 
promise in the fabrication of superior scaffolds. By incorporated the micron thick 
fibres with nanofibrous scaffolds may potentially create 3D constructs with large 
pore sizes, enabling cell and nutrient infiltration through scaffold, while eliminating 
waste.  
 
Significant successes have been demonstrated in this study as we’ve accomplished 
establishing a commercial electrospinning apparatus, with reproducible, optimal 
parameters for polymer blends incorporating PEO, collagen and agarose and/or 
alginates. In addition, fabrications of PEO/agarose/cα-MEM electrospun scaffolds 
have the potential to aid in advancing TE applications. However, it’s been elucidated 
throughout the polymer study that, these are primary investigations, and further 
investigations are required. In addition to scaffold durability, essential scaffold 
properties such as fibre tensile, porosity and permeability measurements still need to 
be investigated, for these scaffolds. 
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Chapter 5 
Cellular and immunological analyses of bio-
electrosprayed mBMSC and the development of the 
bio-electrospray process as a cell delivery method to 
target sites at low voltages 
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5.1 Introduction 
Current gold standard treatments for replacing damaged tissue in TE involve the use 
of autografting and allografting. Various problems associated with these methods 
include lack of donor availability, risk of infection, rejection, disease transmission 
from donor to patient and GvHD (Younger and Chapman (1989). Similarly, serious 
concerns have arisen in connection to existing patient MSC cell therapy. To date, 
MSC are predominantly administered through I.V. injection, which allows cells to 
move through the blood stream to any site in the body, regardless of the intended 
target site. The efficiency of MSC targeting the injury site can be low. Furthermore, 
a well-documented phenomenon, MSC entrapment, can occur after MSC are 
administrated by I.V. injection whereby MSC remain in the lungs and liver of 
rodents (Eggenhofer et al., 2012). This has also been reported in patient trials 
(English et al., 2010; Nystedt et al., 2013). As a result, careful patient monitoring is 
essential due to high risk of acute or chronic adverse side effects from entrapment of 
cells in the lungs or liver.   
 
With the global market for TE estimated to grow to $89.7 billion by 2016 
(bcresearch for TE), and cell therapy market valued to be worth close to $8.8 billion 
by 2016 (Syed and Evans, 2013), developing new substitute treatments in these 
fields is critical. Electrospinning polymers to fabricate artificial 3D scaffolds, has 
excelled in the last two decades as a progressive cell delivery method for TERM 
purposes.  
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While critically analysing our results (Chapter 4), in combination with reports from 
numerous other investigations, it became clear that similar difficulties associated 
with scaffold surface texture, fibre morphology, fibre and pore sizes are continuously 
occurring. The wide variation in electrospinning apparatuses and polymers used 
contribute to lack of a permanent solution in addressing these issues.  
 
This study focuses on providing an alternative cell delivery method wherein cells are 
directly sprayed onto a targeted injury site. Employing the optimal parameters 
established in chapter 3 for the Spraybase
®
 apparatus, we proposed using the BES 
process to electrospray mBMSC directly to injury sites. However, limited 
investigations into viability and functionality of the mBMSC post BES were carried 
out in Chapter 3. Therefore, this study analysed the expression of specific surface 
markers, multilineage differentiation, suppression of T- cell activation and pro-
reparative capabilities, for both BES and pipette (control) mBMSC, following the 
jetting process.  
 
Our previous studies have indicated this cell delivery method has potential as an 
alternative strategy for TERM and cell therapies. However, the apparatus set-up of 
connecting the single needle to a syringe, which is then fixed to a pump, is not 
clinically applicable. In addition, the ground electrode cannot be placed in vivo to 
attract the spray towards the injured region.  
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Therefore, the ability of potentially moving from translation into the clinic using this 
technology was introduced by AVECTAS. The company provided our group with 
their newest commercial device, a BES catheter named SprayCell™. SprayCell™ 
electrospray apparatus includes a specially designed catheter which incorporates the 
single needle configuration and ground electrode within the catheter. It fits all type 
of endoscopes allowing for the BES of cells to various body parts, through keyhole 
surgery.   
 
In an effort to demonstrate the viability and function of BES MSC in vivo using this 
catheter, a 3D model using mBMSC and CG scaffolds was developed in vitro. As 
described in chapter 1, GAGs are linear polysaccharides which are found within the 
ECM and on cell surfaces. These are involved in cell-matrix interactions and wound 
healing which induce cells to migrate, infiltrate and differentiate on scaffolds. These 
behave similarly to tissue and crosslinked scaffolds involving GAGs have been 
successfully used in applications including cartilage and bone regeneration (Lee et 
al., 2003; Farrell et al., 2006). Primarily the aim of this study was to determine 
whether mBMSC attached, and differentiated on these scaffold following BES with 
the catheter. A secondary study was to demonstrate that BES chondrocytes also 
attached to the scaffolds, indicating a potential therapeutic for cartilage diseases, 
such as articular-cartilage lesions and osteoarthritis, where there is limited potential 
for wound healing. Using the innovative SprayCell™ device in combination with 
BES methodology, may subsequently enable targeted delivery of MSC and/or other 
cell types to an injury site in vivo, and potentially avoid the complications associated 
with MSC entrapment and the limitations associated with artificial scaffolds. 
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5.2 Bio-electrosprayed mBMSC retain associated surface markers 
Three principle stipulations for MSC characterisation are adherence to plastic, 
specific cell surface marker expression and tri-lineage differentiation (Tropel et al., 
2004). BES mBMSC adherence to plastic has already been determined with cells 
adhering to tissue culture wells after 24 hrs (Fig. 3.5).   
 
In order to confirm the phenotype of the mBMSC population used in these studies, 
surface marker expression was examined pre- and post- BES. Expression of thirteen 
characteristic MSC cell surface markers, as described by the ISCT, were examined 
using flow cytometry (Dominici et al., 2006). Expression of CD105, CD44, Sca-1, 
CD106, CD73, CD90 with no MHC Class I expression and the absence of CD117, 
endothelial marker CD11b, the haematopoietic marker CD45, lymphocyte maker 
CD34, co-stimulatory marker and CD86 and MHC Class II confirmed the expected 
mBMSC phenotype pre- electrospray. Similar results were found for BES mBMSC 
demonstrating that this jetting process did not alter cell surface marker expression in 
these cells (Fig. 5.1) (Table 7). 
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Fig. 5.1 Bio-electrosprayed mBMSC characterisation for cell surface markers. 
BES mBMSC at flowrate of 5μL/min, 30 gauge single needle, 22mm PD and 
voltages ~3-6kV were characterised by staining the cells for variety of cell surface 
markers (red line) against their corresponding isotypes (black line). The cells were 
analysed using flow cytometry with 10,000 events were recorded for each marker. 
mBMSC retained their characteristic profile of surface markers following BES. 
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Table 7: Summary for surface marker expression on mBMSC following BES 
 
Surface Markers Expression 
CD 11b - 
CD 34 + 
CD 44 + 
CD 45 - 
CD 73 + 
CD 86 - 
CD 90 + 
CD 105 + 
CD 106 + 
CD 117 - 
Sca-1 + 
MHC Class l - 
MHC Class ll - 
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5.3 mBMSC differentiated into their multilineages following the bio-
electrospraying process 
By definition, MSC must show multilineage differentiation capability, for example 
towards osteocyte, adipocyte and chondrocyte lineages (Pittenger et al., 1999). 
Therefore the ability of mBMSC to differentiate towards osteoblast, adipocyte and 
chondrocyte lineages for both pipette, and BES cells was examined.  Determining if 
the electrospray process adversely affected this capability is essential when 
promoting this as a potential delivery method for mBMSC. 
 
For osteoblast, adipocyte and chondrocyte differentiation, mBMSC were cultured 
under specific differentiation conditions for 21 days. Cells were then analysed for 
expression of differentiation-specific features. Osteoblasts were stained with Alizarin 
Red S Stain to visualise calcium deposits, adipocytes were stained with Oil Red O 
Isopropanol to visualise fat deposits and RNA was extracted from chondrocytes for 
detection of expression of markers genes. The differentiation markers were observed 
in each of the three lineages for both pipette mBMSC and BES mBMSC (Fig. 5.2 A 
& B).  Similar patterns of calcium and fat deposits were present in pipette mBMSC 
and BES mBMSC differentiated cells. Similarly, expression of aggrecan and 
collagen IIa was increased in both pipette mBMSC and BES mBMSC (Fig. 5.2 C). 
These results indicate that that the differentiation capability of mBMSC is not 
adversely affected by this bio-electrospray methodology. 
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Fig. 5.2 Differentiation of mBMSC following BES. (A) and (B) show successful 
differentiation of pipette and BES mBMSC after 21 days towards osteoblast and 
adipocyte lineages as demonstrated by positive staining calcium deposits and fat 
deposits respectively (x10 magnification). (C) Expression of aggrecan and collagen 
IIa mRNA was detected by PCR in both pipette and BES mBMSC after 21 days 
differentiation towards a chondrocyte lineage. Flowrate of 5μL/min, 30 gauge single 
needle, 22mm PD and voltages ~3-6kVwere used. 
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5.4 Bio-electrosprayed mBMSC suppressed T-cell proliferation 
Suppression of T-cell proliferation in vitro has become synonymous with MSC. This 
important function makes these cells attractive for therapeutic applications (Dwyer et 
al., 1981; Di Nicola et al., 2002; Glennie et al., 2005; Ding et al., 2009). BES 
mBMSC were examined for their capacity to suppress both autologous and 
allogeneic proliferation T-cells. MHC mis-matched splenocytes were cultured with 
both pipette and BES mBMSC, and analysed by CFSE uptake into replicating DNA 
after 72hr. In a second study, identical parameters where implemented with the 
inclusion of Concovalin A (ConA) at day 0. This is a mitogen known for inducing T-
cell proliferation, and was used as a positive control. Although some proliferation 
was identified for both studies, significant immunosuppressive capacity for both 
pipette and BES mBMSC was demonstrated for alloantigen and mitogen driven 
proliferation (Fig. 5.3 A & B).  
 
Results from these studies indicated proliferation of T-cells was significantly 
reduced in the presence of both pipette mBMSC and BES mBMSC, with 4 fold 
proliferation reduction rates respectively compared to controls (Fig. 5.4).  
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Fig. 5.3 BES mBMSC inhibit A) alloantigen and B) mitogen driven spleen cell 
proliferation. Pipette and BES mBMSC were co-cultured with splenocytes from 
BALB/c (donor 1) and C57BL/6 (donor 2) mice for 72h. Proliferation was measured 
by CFSE intake after 72hr and analysed by flow cytometry. Mitogen driven 
proliferation was examined using Con A (5ug/ml) added at day 0. Statistical 
significance determined by ANOVA analysis (p**<0.01), (p***<0.001).  BES 
mBMSC preformed similar to pipette mBMSC in their ability to suppress T-cell 
proliferation. 
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Fig. 5.4 Suppression of T-cell proliferation by mBMSC following BES. T-cell 
proliferation was reduced by 4 fold in the presence of pipette mBMSC and mBMSC 
subjected to BES respectively. This indicated the electrosprayed cells were behaving 
similarly to the non-BES cells. Parameters for the electrospray included flowrate of 
5μL/min, 30 gauge single needle, 22mm PD and voltages ~3-6kV. 
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5.5 Bio-electrosprayed mBMSC induced wound closure for two separate cell 
types 
Studies have shown that MSC migrate to injury sites and promote repair through the 
production of trophic factors, including growth factors, cytokines, and antioxidants 
(Chen et al., 2008; Karp and Leng 2009). Therefore the jetting process was 
investigated to determine whether if it would adversely affect the pro-reparative 
properties of mBMSC. For this study two independent in vitro wound closure assays 
were set-up and wound closure was examined using the A549 and BEAS-2B lung 
epithelial cell lines. Similar results were demonstrated for two studies with both 
pipette and BES mBMSC induced significantly higher rates of wound closure 
compared to controls.  
 
Analysis for A549 assay revealed wound sizes of 16 ±2.2% remained for the pipette 
mBMSC and 15 ±3.1% for the BES mBMSC compared to control wounds. There 
was no significant difference between the wounds remaining in wells treated with 
pipette or BES mBMSC (Fig. 5.5). Similar results were obtained when the BEAS-2B 
lung cell line was used as an alternative to A549 in the wound closure assay. Wound 
closure of 15 ±2.8% remained for pipette mBMSC, with 12 ±3.2% for BES 
mBMSC. Again, no significant differences were observed between pipette and BES 
mBMSC treated wells for wound closure (Fig. 5.6). 
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Fig. 5.5 Enhancement of wound closure by BES mBMSC. A wound was created 
and observed over 24 hr. (A) Crystal violet staining of A549 cells show little to no 
closure to controls. (B) Plates with transwells containing either (i) pipette or (ii) BES 
mBMSC illustrate wound closure. After 20 hr, wound was fully closed in wells 
containing BES mBMSC. (C) % A549 wound closure was significantly enhanced in 
the presence of both pipette and BES mBMSC. (n=3). Statistical significance 
determined by ANOVA analysis (p**<0.01), (p***<0.001).                                               
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Fig. 5.6 Enhancement of wound closure by mBMSC. Second study demonstrating 
wound created and observed over 24 hr. (A) Crystal violet staining of BEAS-2B 
cells show little to no closure to controls. (B) Plates with transwells containing either 
(i) pipette or (ii) BES mBMSC illustrate wound closure. After 20 hr, wound was 
fully closed in wells containing pipette mBMSC. (C) % BEAS-2B wound closure 
was significantly enhanced in the presence of both pipette and BES mBMSC. (n=3). 
Statistical significance determined by ANOVA analysis (p**<0.01), (p***<0.001). 
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5.6 Bio-electrospray of various cell types using commercial electrospray  
In addition to MSC, it may be appropriate in some situations to deliver differentiated 
cells types for in vivo therapeutic applications. As previously reported a number of 
cell types have been electrosprayed using in-house systems (Abeyewickreme et al., 
2009; Sahoo et al., 2010; Bartolovic et al., 2010; Ng et al., 2011; Guan et al., 2009; 
Ye et al., 2014). Therefore electrospraying of different cell types was examined 
using Spraybase
®
 at the optimised parameters with flowrate of 5μL/min, 30 gauge 
single needle, 22mm PD and voltages ~3-6kV.  
 
Osteocytes and adipocytes obtained from differentiated mBMSC as described in 
section 2.8.2 and 2.8.3 respectively, were BES using the Spraybase
®
 apparatus at 
low voltages (5kV). Parameters were identical to those used for mBMSC except that 
PD was changed from 22 mm to 25 mm to avoid spark generation due to the higher 
conductivity of these cell suspensions compared with mBMSC suspensions. Cells 
were subjected to BES, collected in 6 well plates, cultured for 24 hr and then stained 
with either alizarin red, for calcium deposits in osteocytes, or Oil red O, for fat 
deposits in adipocytes. Calcium and adipose deposits were observed in the respective 
cell types and there were no visible differences between these cells and pipette 
counterparts (Fig. 5.7). This indicates that differentiated cells, as well as MSC, can 
be delivered to substrates using Spraybase
®
 without adverse effects on cell 
functionality. 
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Fig. 5.7 BES Bone and Fat deposits. (A) (i) Pipette and (ii) BES calcium deposits. 
(B) (i) Pipette and (ii) BES adipose deposits. Both cells were BES using flowrate of 
5μL/min, 30 gauge single needle, 22mm PD and voltages ~3-6kV and the results 
showed they adhered to 6-well plate after 24 hr. Staining with either alizarin red (for 
calcium deposits) or Oil red O (for adipose deposits) demonstrated that both the 
calcium and adipose deposits could be electrosprayed with no apparent damage to 
the aggregates themselves when compared to pipette control after 24hr. 
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5.7 Addition of catheter to electrospray apparatus developed more medically 
applicable device named SprayCell™ 
Addressing critical issues associated with MSC therapies and TERM involved 
developing an alternative strategy for MSC delivery to target sites. Therefore the 
addition of the specially designed catheter, SprayCell™, by AVECTAS, provided a 
more medically applicable BES system.  
 
In addition to the basic electrospray set up, SprayCell™ system includes IEC 
standard approved power supply unit, laser and camera visualization system and 
most importantly the addition of the catheter. This catheter incorporates the single 
needle configuration and ground electrode within its specially designed outer tubing. 
This is then attached to syringe in place of the needle (Fig. 5.8). The catheter fits all 
types of endoscopes, making it possible to deliver cells directly to a target site, 
through keyhole surgery (Fig 5.9).  
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Fig. 5.8 SprayCell™ Configuration. Addition of specially designed catheter with 
incorporated single needle configuration and ground to electrospray apparatus 
supplied by AVECTAS. Set up retains IEC standard approved power supply unit, 
with laser and camera.  
A 
B 
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Fig. 5.9 Specially designed catheter for SprayCell™. (A) Illustrates length of 
catheter with syringe containing mBMSC in complete culture medium attached. (B) 
Depicts the catheter within an endoscope. For this demonstration a bronchoscope 
was used to indicate catheter length can be modified to fit all types of endoscopes, 
regardless of size, making it applicable for all types of keyhole surgeries. 
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5.8 Adherence of mBMSC onto 3D collagen-glycosaminoglycan scaffold post 
bio-electrospray using SprayCell™ 
To date our studies consisted of 2D experiments which are sufficient for 
investigations into mBMSC viability and function following electrospraying. 
However, to move towards a more medically applicable cell delivery strategy, it 
became essential to have more comprehensive results. Therefore mBMSC were BES 
onto the spongy type 3D CG-scaffolds using SprayCell™ and their adhesion 
capabilities were examined. 
 
Using optimised parameters established for Spraybase
®
, mBMSC were BES at 1x 
10
6
 cells/mL using Spraycell™ onto CG-scaffolds. Voltage remained at 6kV 
irrespective of RH with flowrate 10μL/min to compensate for distance travelled by 
cells through catheter. mBMSC were then stained with  DAPI and MitoTracker Red 
and analyses from immunofluorescence microscopy demonstrated that the cells had 
successfully adhered on the scaffolds after 24hr (Fig. 5.10).  
 
mBMSC viability was also analysed using same 7-AAD exclusion assay as shown 
for BES cells using Spraybase
®
. It was found that 94 ± 2.08% mBMSC cells 
remained viable following electrospraying with SprayCell™ compared with 97 ± 
1.21 for pipette cells. Interestingly, when compared to those BES using Spraybase
®
, 
viability using SprayCell™ had increased by approx 14% (Fig. 5.11).  
 
 
 
 
164 
 
  
 
Fig. 5.10 Adhesion capabilities of BES mBMSC onto CG-scaffolds using 
SprayCell™. (A) and (B) DAPI and MitoTracker Red staining of mBMSC 24hr 
after electrospraying using SprayCell™ at x10 and x20 respectively. mBMSC were 
BES using SprayCell™ onto CG scaffolds at flowrate of 10μL/min, 30 gauge single 
needle, 22mm PD and voltage 6kV, and immunofluorescence determined cells 
adhered to the scaffolds after 24hrs.  
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Figure 5.11 Viability of BES mBMSC for SprayCell™. (A)Viability of mBMSC 
was 94 ± 2.08% following BES with SprayCell™ compared with 97 ± 1.21% for 
pipette cells (n=3). (B) Viability of mBMSC was 80 ± 1.3% following BES with 
Spraybase
®
 compared with 90 ± 1.5 for pipette cells (n=3). High yields of viable 
mBMSC are electrosprayed when using both systems. However, results also 
indicated increased viability (approx 14%) with catheter (SprayCell™) compared to 
apparatus without (Spraybase
®
). Statistical significance determined by ANOVA 
analysis (p**<0.01), (p***<0.001).  
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5.9 Bio-electrosprayed mBMSC shown to penetrate deeper into collagen-
glycosaminoglycan scaffolds in comparison to pipette control 
Organs and body structures are composed into multiple tissue types including 
connective, muscle, nervous and epithelial. Each of these varies in thickness from 
nano to micro metre scale. In order to demonstrate mBMSC BES with SprayCell™ 
can penetrate through composites, cell penetration through the scaffold was 
examined following electrospray. Confocal microscopy demonstrated the BES 
mBMSC penetrated deeper into the scaffold compared to cells delivered using a 
micropipette after 24hr (Fig. 5.12).   
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Fig. 5.12 Permeation of BES mBMSC through CG-scaffolds using SprayCell™. 
Confocal microscopy demonstrated that mBMSC delivered onto scaffolds with 
SprayCell™ at penetrated deeper through scaffold after 24 hr compared with cells 
delivered using a pipette (n-3).  
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5.10 mBMSC bio-electrosprayed using SprayCell™ apparatus differentiated 
into chondrocytes on collagen-glycosaminoglycan scaffolds. 
Chondrocytes are the only cells present in cartilage, and their death by apoptosis 
contributes to cartilage loss in joint diseases, such as OA (Buckwalter and Mankin, 
1997; Gilbert 1998; Messner and Gillquist). The ability of mBMSC to differentiate 
along a chondrocyte lineage following BES onto scaffolds was examined. mBMSC 
were BES onto CG-scaffolds and cultured in chondrocyte differentiation medium for 
21 days. Scaffolds were then stained with toluidine blue O such that cartilaginous 
extracellular matrix stained purple (metachromasia) while undifferentiated or fibrous 
tissue stained blue (scaffold).  Successful differentiated of electrosprayed mBMSC 
into chondrocytes was demonstrated with purple cells evident and scattered around 
the scaffold (Fig. 5.13 B). Control involved culturing pipette mBMSC within a 
15mL polypropylene tube in chondrocyte differentiation medium for 21 days. Result 
demonstrated singular differentiated chondrocyte pellet which was placed onto 
scaffold. Staining with toluidine blue O demonstrated clear metachromasia in pellet 
(purple), on the blue stained scaffold (Fig. 5.13 A). BES differentiated pellets 
appeared similar to pipette control on scaffold.  
 
Chondrocyte differentiation was further verified for BES mBMSC when RNA was 
extracted from the scaffolds and expression of chondrocyte marker genes aggrecan 
and collage IIa was demonstrated using RT-PCR (Fig. 5.13 C).   
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Fig. 5.13 Differentiation of mBMSC towards a chondrocyte lineage following 
BES onto CG-scaffolds. (A) mBMSC cultured in 15mL polypropylene tube in 
chondrocyte differentiation medium for 21 days was placed onto scaffold. (B) 
mBMSC were BES onto CG-scaffolds using SprayCell™ and cultured in 
chondrocyte differentiation medium for 21 days. Chondrocytes were detected by 
staining scaffolds with toluidine blue O. Purple stain indicates cartilaginous 
extracellular matrix of chondrocytes while undifferentiated cells and scaffold stained 
blue (x10 magnification). (C) Expression of aggrecan and collagen IIa mRNA was 
detected by RT-PCR for BES mBMSC after 21 days differentiation towards a 
chondrocyte lineage on scaffolds. 
 
 
mBMSC 
BES 
Chondr 
Differn 
BES 
mBMSC 
BES 
Chondr 
Differn 
BES 
Aggrecan 
GAPDH 
Collagen 
IIa 
GAPDH 
C 
B A 
170 
 
5.11 SprayCell™ capable of bio-electrospraying chondrocytes directly to 
specific target site  
We have demonstrated that bone and fat cells can electrospray using Spraybase
® 
(Fig. 5.7) at low voltages (5kV).  We therefore examined whether SprayCell™ could 
replicate these results using differentiated cartridge cells. Chondrocytes obtained 
from differentiated mBMSC as described above were BES onto CG-scaffolds using 
SprayCell™ at low voltages (6kV). A specific site located on the scaffold was 
targeted with the spray. After 24 hr, the scaffold was stained with toluidine blue O. 
Chondrocyte aggregates were observed at the specific target site on the scaffold (Fig. 
5.14). This indicates that differentiated cells, as well as MSC, can be delivered to 
substrates using BES method without adverse effects on cell functionality. 
Furthermore, in contrast to pipette delivery, it is possible to target cells to a specific 
location on a scaffold using the SprayCell™ electrospray catheter regardless of area 
size. 
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Fig. 5.14 BES of differentiated chondrocytes onto CG-scaffolds using 
SprayCell™. mBMSC were differentiated towards a chondrocyte lineage and then 
delivered onto CG-scaffolds using SprayCell™. Photomicrographs demonstrate 
aggregates of chondrocyte at 24 hr post-BES onto CG-scaffolds at (A) x10 
magnification and (B) x40 magnification.  
 
 
 
 
 
 
 
 
 
 
172 
 
5.12 Discussion 
Serious problems with donor availability, infection, rejection, and GvHD are 
associated with current gold standard methodologies for TERM. In addition, MSC 
cell therapies experience problems associated with I.V. injections which may prevent 
cells reaching an intended target site, while also presenting a dangerous phenomenon 
named MSC entrapment. As a result alternative substitutes are being developed for 
these therapeutic applications. Significantly, fabrication of functional scaffolds using 
the electrospinning process is currently dominating the TE field. This is due to the 
processes easy fabrication of nanofibres from polymers which can provide an 
artificial platform for cellular implantation, which mimics the natural ECM in vivo. 
However, difficulties with scaffold surface texture, fibre morphology and pore and 
fibre sizes still remain due to large variations in electrospinning apparatuses, and 
polymers used for this process. Therefore, the aim of this study evolved towards the 
development of an alternative strategy for cell delivery, wherein the cells are 
electrosprayed directly towards a targeted injury region, potentially eliminating 
problems associated with scaffolds and I.V. injections for in vivo applications. 
 
Successful electrospraying of mBMSC using Spraybase
®
 at low voltages (~3-6kV) 
have been demonstrated using optimal and reproducible parameters (Chapter 3). Cell 
viability, morphology and adherence to plastic were investigated in which the cells 
displayed similar behaviours to their pipette control counterparts (Fig. 3.5 and Fig. 
3.8). However, as with previous studies, a full phenotypic analysis of MSC post BES 
had not been described (Sahoo et al., 2010 and Ye et al., 2014). Therefore, a key part 
of this study was the analysis of the effects low voltage electrospraying had on 
mBMSC function.  
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MSC are characterised after they are isolated from a tissue and cultured ex vivo. This 
is to prove the isolated cells are non- hematopoietic MSC. Tropel et al., (2004) 
described adherence to plastic, surface marker expression and multilineage 
differentiation as three fundamental characteristics associated with MSC. In the 
present study, specific assays demonstrating surface marker expression and 
multilineage differentiation were conducted for both isolated MSC from mouse bone 
marrow, and BES mBMSC. By using identical characterisation assays for both 
isolated and BES mBMSC, this indicated if the low-voltage electrospray process 
adversely affected the BES cells, when compared to their non-BES counter parts. It 
was confirmed that expression of thirteen markers described by ISCT were either 
present or absent as appropriate for the BES cells (Fig. 5.1). Similar results were 
observed when the electrosprayed mBMSC differentiated into osteocytes, adipocytes 
and chondrocytes after 21days (Fig. 5.2). These results support the concept that low-
voltage BES had no perturbing adverse effects to mBMSC. 
 
Another significant feature for MSC is the modulation of lymphocytes through 
inhibition mechanisms occurring via various pathways involving cell contact and 
soluble factors (Di Nicola et al., 2002, Krampera et al., 2003). One method MSC are 
believed to modulate T cells is through direct suppression of proliferation, as it has 
been reported that T cells cultured with MSC did not progress past G1 phase of the 
cell cycle (Glennie et al., 2005). The inability of this trait to function can lead to 
major consequences in clinical trials where MSC have been used to treat patients. 
For example, increased T cell proliferation in patients with GvHD can enhance an 
immune response resulting in graft rejection.  
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Similarly, by suppressing T cell activation in patients with autoimmune diseases can 
potentially stop an immune response and the immune system attacking itself. 
However, if this function is compromised, T cell proliferation can activate an 
immune response which can be detrimental to the patient. Therefore, it was 
imperative to investigate the immunosuppressive effects of mBMSC following 
electrospraying. Analyses from two studies examining suppression of alloantigen 
and mitogen driven T-cell proliferation, indicated low-voltage BES did not 
compromise this vital characteristic of mBMSC. Although a small amount of 
proliferation occurred for both studies, T-cell proliferation was significantly reduced 
by 4 fold in the presence of pipette mBMSC and mBMSC subjected to BES 
respectively (Fig. 5.3 and Fig.5.4).  
 
MSC have been reported to induce repair through cell education and trophic 
manipulation of the micro-environment (Phinney and Prockop, 2007, Caplan and 
Dennis, 2006). Given the heterogeneity of in vitro cultured MSC, the concepts of 
regeneration and trophic repair may not be mutually exclusive, (Phinney and 
Prockop, 2007, English et al., 2013). This suggests that if MSC are heterogeneous 
mixed populations, the regeneration effects may be performed by different sub-
populations. However, in order to determine if low-voltage affected mBMSC pro-
reparative properties, in vitro assays were used. BES mBMSC were evaluated in 
vitro when two separate cell lines were monitored for wound closure, over 24hrs. 
Results implied that trophic factors from either pipette or electrosprayed mBMSC 
induced wound closure for each cell line, as medium only control containing growth 
factors and no cells resulted in little to no wound closure (Fig. 5.5 and Fig. 5.6).  
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This indicates that BES mBMSC pro-reparative capabilities are not adversely 
affected by low-voltage electrospraying using Spraybase
®
, suggesting similar results 
may occur for in vivo regeneration and/or trophic repair.  
 
A full phenotypic analysis of mBMSC following low-voltage electrospraying using 
Spraybase
®
, provided critical data in suggesting this jetting process has potential as 
an alternative cell delivery method, for TERM and cell therapy applications. It was 
confirmed that BES mBMSC maintained vital cellular and immunological 
characteristics similar to pipette controls, indicating the low-voltage electrospraying 
did not affect these abilities. Spraybase
®
 is a benchtop instrument and its 
configuration is more suitable for laboratory experiments. Therefore, in promoting 
BES as a cell delivery method it was necessary to have an apparatus that was more 
medically applicable.  
 
Procuring the electrospray device, SprayCell™, provided the instrument required for 
medical environments. SprayCell™ specially designed catheter is the systems most 
unique and essential component. To date, no other electrospray apparatus has been 
constructed with such a feature. The catheter incorporates both the single needle and 
ground electrode within the catheter tubing, and can be modified to fit any type 
endoscope for keyhole surgery. Thus, this generated a jetting device which is 
compatible with in vivo applications (Fig 5.8 and Fig. 5.9). Interestingly, unlike the 
Spraybase
® 
apparatus where voltage fluctuated between ~3-6kV due to RH of the 
lab, voltage for SprayCell™ remained at 6kV throughout all experiments. This is a 
crucial improvement for the use of this method in medical environments, as theatres 
are generally monitored at constant temperatures and RH.  
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Therefore, it is suggested that the settings of these environments will not impact on 
the low-voltage applied for MSC administration, ensuring this method is safe for 
both the user and patient.  
 
Furthermore, although it was necessary to adjust the flowrate to accommodate 
endoscope length, it was shown that the addition of the catheter provided higher cell 
viability compared to Spraybase
®
 apparatus (Fig 5.11). One suggestion for this is 
possibly due to the tubing protecting the cells from the force of the spray, causing 
less shearing, which ultimately leads to cell death. 
 
In order to assess the potential behaviours of BES MSC in vivo a comprehensive 3D 
study using CG scaffolds and SprayCell™ electrospray was carried out. The results 
from these investigations demonstrated BES mBMSC adhered to the scaffold, but 
more significantly, penetrated deeper into the scaffold compared to their pipette 
counterparts (Fig. 5.10 and Fig. 5.12). As tissues vary in thickness this may prove to 
be an essential attribute for the electrospraying method for in vivo applications. 
Furthermore, it was demonstrated that BES mBMSC differentiated into 
chondrocytes on scaffolds indicating the cells maintained their functions (Fig. 5.13). 
The last decade has seen a major focus towards developing novel therapeutic 
strategies for cartilage defects. Current medical treatments lack in techniques to 
regenerate articular-cartilage, and existing therapeutic treatments only alleviate pain 
instead of controlling disease progression.  
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BES MSC directly to injured cartilage areas using SprayCell™ device, through 
keyhole surgery, may hold some potential towards new articular-cartilage 
regeneration therapeutics. As mBMSC have been shown to adhere and differentiate 
into chondrocytes on CG-scaffolds, it suggests similar results may be attained for in 
vivo purposes.  
 
Furthermore, this study also proposes to BES chondrocytes to injured regions with 
the potential to enhance previously developed cartilage regeneration therapies such 
as the ACI method.  Autologous chondrocyte implantation is considered new and 
effective therapy aimed at re-establishing the articular tissue. This was shown in a 
study by Frisbie et al. (2008) when they evaluated ACI transplantation via a collagen 
membrane in equine articular defects. However, in addition to immune rejection, a 
major obstacle for autologous transplantation is the lack of large numbers of 
chondrocytes available. Issues with maintaining chondrocyte viability during in vitro 
expansion has also proven problematic (Ashraf et al., 2015). Our final study 
demonstrated successful electrospraying of chondrocytes to a specific area at low 
voltages of 6kV. Cells adhered to scaffolds after 24 hr at a specific targeted site (Fig. 
5.14). This demonstrates potential for advancing ACI such that BES autologous 
chondrocytes using SprayCell™ directly to injured sites may possibly eliminate 
problems with scaffold transplantation and immune rejection. It may also aid 
problems associated with cell numbers and viability.  
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Chondrocytes have been reported to respond slowly to trauma such as articular-
cartilage lesions, demonstrating limited proliferative capacity and a reduced potential 
for the de-novo synthesis of an extracellular matrix in vivo (Shapiro et al., 1993; 
Hunziker 2002).  
 
Our hypothesis is to BES in vitro cultured autologous chondrocytes to a defected 
cartilage area, wherein the cells adhere and potentially divides into daughter cells in 
vivo. These daughter cells will originate as chondroblasts which can potentially 
secrete new ECM while maturing into new chondrocytes at the source of the defect.  
Moreover we also suggest the possibility wherein the new electrosprayed 
chondrocytes may stimulate signally pathways of its surrounding microenvironment, 
potentially inducing an immune response to close the lesion wound, before it 
escalates to the onset of OA. 
 
In addition, this study demonstrates the accuracy of controlled spray from the 
catheter. Lack of toluidine blue O staining on scaffold except at designated 
chondrocyte sites, suggests chondrocytes electrosprayed solely to intended area of 
scaffold. This supports our hypothesis in employing SprayCell™ to directly BES 
MSC/chondrocytes to injured regions, as an innovative delivery strategy for 
cell/regenerative therapies.  
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In summary, MCS hold great promise as therapeutic entities and as such are 
receiving significant levels of attention. However, the challenges encountered with 
current delivery methods illustrate that new and innovative methods for MSC 
administration are required. BES holds potential as a delivery method for MSC, and 
other cell types, as it could enable direct delivery of known number of cells to a 
target area in vivo. This is a critical step towards the translation of electrospray 
technologies for delivery of cells for therapeutic purposes in vivo.  
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Conclusions and Future Directions 
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6. Conclusions  
Employing jetting methodologies to deliver live cells is as still a relatively new 
concept. This study evaluated a commercial electrospray instrument which permitted 
the establishment of standardised optimal parameters to BES cells, generating a 
system for reproducing data between experiments and potential medical 
environments. In addition, it was proven that a stable Taylor cone of cells in 
suspension can be achieved using a single needle configuration at low voltages, a 
result not yet reported. High yields of viable cells can BES using either the bench-
top, or the medically designed electrospray apparatuses, at low voltages. Essential 
cellular and immunological characteristics of mBMSC were demonstrated to behave 
similar to those of non-BES counterparts, indicating that the low voltages did not 
adversely affect the cells. This was shown for 2D and 3D experiments. Finally, 
electrosprayed cells were shown to deliver directly to a target site either in culture 
wells or on scaffolds, while distributing in equal volumes. These studies have 
demonstrated that BES possesses the potential to be a delivery method for MSC, and 
other cell types, as it could facilitate direct delivery of known number of cells to a 
target area in vivo. This is a significant result in moving the electrospray process 
forward, taking the BES of cells from “bench to beside” for therapeutic purposes in 
vivo. 
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The commercial electrospray was also shown to electrospin fibres at the nano and 
mirco scale, for newly designed polymer blends, at reproducible optimal parameters. 
The fabrication of two contrasting 3D constructs involving collagen and agarose, 
demonstrated how various parameters affect scaffold surface texture, fibre 
morphology and fibre and pores sizes, characteristics essential for functional 3D 
scaffolds for TERM. 
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7. Future Directions  
This work involved using MSC for applications involved in TERM and cell therapy 
purposes. All experiments were performed using BMSC derived from mice. Future 
experiments should use either autologous expanded human MSC, or the genetically 
reprogrammed adult stromal cells, iPSC. Performing the same characteristic assays 
on BES hMSC or BES iPSC, can potentially give more accurate results of the effects 
low-voltages electrospraying may have on the cells in vivo. BES autologous 
harvested cells may also reduce issues with heterogeneity of in vitro cultured MSC, 
such that the concepts of regeneration and trophic repair may not be mutually 
exclusive. 
 
In addition, the optimisation of a commercial electrospray for the BES of cells at low 
voltages demonstrated vital cellular and immunological characteristics behaved 
similar to their non-BES counterparts. All assays, except for chondrocyte 
differentiation, were performed using 2D culture systems. Therefore, conducting the 
osteogenic and adipogenic differentiation assays on MSC electrosprayed onto 3D 
scaffolds will give more accurate results to the differential potential of MSC in vivo, 
when BES at low voltages. 
 
The aforementioned are preliminary studies for future work, and will be followed by 
investigations into the most critical future direction for the BES of MSC as a cell 
delivery strategy. These will include examining if BES MSC can adhere, proliferate, 
differentiate and induce wound healing at an injured region in vivo, using the 
medically designed electrospray apparatus with catheter. The purpose of this catheter 
is to fit all types of endoscopes.  
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Therefore, it is necessary to carry out keyhole surgeries using animal models, where 
in MSC are BES at low voltages to injuries at various sites of the animal body, 
relevant to MSC therapies. This would allow complex experimental data to be 
evaluated for the effects low-voltage BES has on MSC viability and function 
capabilities, specifically differentiation and pro-reparative properties necessary for 
TERM applications. In addition, it is essential to investigate the immunosuppressive 
properties of BES MSC in vivo. Using animal models for GvHD disease can give 
excellent experimental data for the immunosuppressive capabilities of BES MSC, 
which is essential for cell therapy purposes.  
 
Following examination of the affects low-voltage BES has on MSC in vivo, 
investigations into electrospraying autologous expanded chondrocytes to articular-
cartilage lesions will be crucial, to promote new possibilities for cartilage 
regeneration therapy. BES autologous chondrocytes through arthroscopy using the 
electrospraying catheter to cartilage lesions in vivo, will demonstrate if cells can 
adhere to the injured site without the aid of scaffolds. In addition, it will allow 
assessment of the ability of chondrocytes to induce new chondroblasts, which 
ultimately produces new chondrocytes and cartilage ECM, post BES, resulting in 
either a more enhanced ACI therapy or the generation of a new regenerative cartilage 
therapy. 
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Future directions for agarose electrospun fibres may hold some promise in the 
fabrication of superior scaffolds. Incorporating the micron thick fibres with 
nanofibrous scaffolds may potentially create 3D constructs with large pore sizes, to 
enable cell and nutrient infiltration through scaffold, while eliminating waste, 
possibly assisting in advancing TE applications. It is necessary to examine critical 
scaffold properties such as fibre tensile, porosity and permeability measurements for 
these scaffolds. In addition, investigations into cellular activity upon and through 
these scaffolds are also essential for future applications. 
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           Jet mode - 3 x 106 mBMSC/mL BES with central ligament of cells at ~3-6kV 
         
 
 
 
        Jet mode - 3 x 106 mBMSC/mL BES with central ligament of cells at ~3-6kV 
         
 
Fig. A1 Replicas of Jet Spray modes achieved with electrospray set-up. 3 x 10
6
 
mBMSC/mL suspended in cα-MEM culture medium were BES at 3-6kV (depending 
on RH), flowrate of 5µL/min, PD of 22 mm (A) Jet mode with central ligament of 
cells visible recorded on the 5
th
 September 2013. (B) Jet mode with central ligament 
of cells visible recorded on 12
th
 December 2013. All photographs were taken 1 
frame/second for 5 frames. 
 
Key: (i) Needle (ii) Taylor cone (iii) jet mode with central ligament of cells (iv) 24 - 
well plate 
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               Plume spray – 1 x 106 mBMSC/mL BES at ~3-6kV 
       
 
 
                Plume spray – 1 x 106 mBMSC/mL BES at ~3-6kV 
       
 
Fig. A2 Replicas of Plume Spray achieved with electrospray set-up. 1 x 10
6
 
mBMSC/mL suspended in cα-MEM culture medium were BES at 3-6kV (depending 
on RH), flowrate of 5µL/min, PD of 22 mm (A) Plume spray visible recorded on the 
11
th
 September 2013. (B) Plume spray visible recorded on 18
th
 December 2013. All 
photographs were taken 1 frame/second for 5 frames. 
 
Key: (i) Needle (ii) Taylor cone (iii) plume spray of cells (iv) 24 - well plate 
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Fig. A3 Graphical representation for the measurements of pore sizes for 
collagen and agarose scaffolds. 10 random pore sizes were selected and measured 
using SEM for both constructs. (A) Demonstrates the mean pore size for collagen 
and agarose scaffolds. The mean pore size for collagen scaffolds was shown to be 
41.96μm, while agarose scaffolds were recorded at 6.2μm. (B) Demonstrates 
inconsistent pore measurements for the collagen scaffolds, with the smallest pore 
size measured at 10.1 μm and the largest recorded at 75.1μm. In contrast the pore 
size for the agarose scaffolds, although small, indicated they were uniform. The 
smallest pore size for the agarose scaffolds was recorded at 5.97μm and the largest at 
6.38μm. 
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Fig. A4 Graphical representation for the measurements of fibre thickness for 
collagen and agarose scaffolds. 10 random fibres were selected and measured using 
SEM for both constructs. (A) Demonstrates the mean fibre thickness for collagen 
and agarose scaffolds. The mean fibre thickness for collagen scaffolds was shown to 
be 1.79μm, while agarose scaffolds were recorded at 1.56μm. (B) Demonstrates the 
inconsistencies in fibre thickness for the collagen scaffolds, with the thinnest fibre 
measured at 795nm and the thickness recorded at 3.18μm. In contrast the fibre 
thickness for the agarose scaffolds indicated they were uniform in diameter, although 
they remained at the μm scale. The thinnest fibre for the agarose scaffolds was 
recorded at 1.57μm and the thickest at 1.58μm. 
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B 
